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Long-chain polyunsaturated fatty acids (LCPUFA) are essential for infant growth 
and development, and amounts in breast milk depend on maternal diet and body stores.  
Because exercise increases mobilization and utilization of fatty acids, maternal activity 
may also influence the amount of LCPUFA in breast milk.  In addition, exercise has been 
shown to improve bone mineral density (BMD) in postmenopausal women.  During 
lactation, bone turnover is elevated to provide calcium for breast milk.  This results in 
decreased BMD.  
Therefore, the purpose of these studies was to: 1) investigate the effects of diet 
and exercise on fatty acid concentrations in maternal plasma and breast milk, and 2) 
determine the effects of a specific resistance and aerobic training program and dietary 
intake on BMD and bone turnover during lactation. 
In the first study, LCPUFA in plasma and breast milk were measured at 12 weeks 
postpartum in exercising and sedentary women.  Dietary intake was recorded for three 
days.  A subsample of women participated in exercise and rest sessions to examine the 
acute effects of exercise on breast milk LCPUFA.  In the second study, whole body, 
lumbar spine (LS) and hip BMD and bone mineral content (BMC), and bone turnover 
markers were measured before and after a 16-wk intervention in breastfeeding women 
who either participated in a specific resistance and aerobic training program or were 
sedentary.  Dietary intake and body composition were also assessed in all women. 
 
In the first study, there were no differences in essential fatty acid intake between 
the two groups.  Intake of linoleic acid (LA) was 11.05 ± 1.39 and 9.34 ± 0.97 and α-
linolenic (LNA) was 0.96 ± 0.12 and 0.82 ± 0.09 grams/day for the sedentary and 
exercise groups, respectively.  No differences were found in LCPUFA in plasma and 
breast milk between groups.  After 30 minutes of exercise, there was a trend for an 
increase in LA and LNA.  In the second study, exercising women lost significantly less 
LS BMD and LS BMC (p<0.05), and had substantial improvements in body composition.  
Calcium and protein intake were significant predictors of whole body BMD loss with 
parity being a significant covariate (p<0.05).  Bone turnover markers were also 
significant predictors of LS BMD and LS BMC, when adjusted for parity and exercise 
(p<0.01). 
These results suggest that women consuming adequate amounts of LCPUFA can 
exercise moderately without decreasing the LCPUFA in their breast milk.  In addition, 
increased calcium and protein intake lessens BMD loss during lactation.  In breastfeeding 
women, moderate resistance and aerobic exercise was effective in improving body 
composition and minimizing BMD losses.   
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INTRODUCTION 
 
 
 Breastfeeding confers many life long health benefits to both mother and child.  
The following research studies have investigated the effects of moderate exercise during 
lactation on maternal health status and breast milk composition.  Exercise during 
lactation benefits the mother through increased fitness and improved body composition.  
Breast milk alone provides the infant with optimal nutrition, and maternal exercise does 
not negatively impact the quality of breast milk.   
The first research study examined the effects of exercise and diet on plasma and 
breast milk fatty acids.  Exercise leads to a mobilization of fatty acids from body stores, 
and these fatty acids may further be mobilized to breast milk.  It is well documented that 
the n-6 and n-3 fatty acids, specifically docosahexaenoic acid (DHA) and arachidonic 
acid (AA), accumulate in the brain and retina of infants, and this accumulation is 
important for the neural and visual development of the infant.   
The second study examined the effects of diet and exercise, during lactation, on 
maternal body composition, bone mineral density, and bone turnover markers.  It is well 
established that lactation leads to loss of bone, specifically in the spine and hip regions.  
These losses are usually recovered upon weaning; however, recovery does not occur in 
all women.  If bone density remains low, women may be at a higher risk for developing 
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osteoporosis later in life.  Exercise has been shown to be an effective means to 
improve bone mineral density in postmenopausal women.  These research studies were 
guided by the following specific aims: 
Study 1 
Specific Aim #1: To determine the effects of moderate exercise on plasma and 
breast milk fatty acid composition. 
Hypothesis:  Exercise will have no effect on basal concentrations of plasma and 
breast milk long-chain polyunsaturated fatty acids (LCPUFA) between sedentary and 
exercising women.  Acutely, concentrations of LCPUFA in breast milk would remain the 
same after a 30-minute rest session, while increasing after a 30-minute exercise session 
because of increased mobilization of LCPUFA from maternal fat stores.  Chronic, 
moderate exercise will have no negative effect on plasma and breast milk fatty acids. 
Specific Aim #2:  To determine the effects of dietary intake on plasma and 
breast milk fatty acid composition. 
Hypothesis:  There will be no effect of dietary intake on plasma and breast milk 
fatty acid composition. 
Study 2 
Specific Aim #1: To determine if an exercise intervention will minimize BMD 
losses in lactating women from 3 weeks postpartum to 21 weeks postpartum. 
 Hypothesis:  Lactating women participating in a 16-week exercise program will 
have less BMD loss in comparison to non-exercising controls, as measured by dual 
energy x-ray absorptiometry (DXA), specifically in the lumbar spine region.   
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Specific Aim #2:  To determine if an exercise intervention will decrease bone 
losses due to increased bone formation and decreased bone resorption from 3 weeks 
postpartum to 21 weeks postpartum. 
Hypothesis:  Women in the control group will have normal physiological changes 
in bone markers.  In these women, a slow increase in serum bone-specific alkaline 
phosphatase (BAP) levels (bone formation marker) is expected; however, urinary 
pyridinium crosslinks (bone resorption marker) will slowly decline during the study 
period.   These changes are normal adaptations after pregnancy, in which the body is in a 
state of very high bone resorption and low bone formation.  Exercise training will result 
in slower decline, compared to controls, in bone resorption, and greater increase in bone 
formation, indicating a slowing of overall bone turnover.     
Specific Aim #3: To determine if an exercise intervention will improve body 
composition (lean and fat mass), muscular strength, and cardiovascular fitness levels 
in lactating women over the 16-week fitness program. 
 Hypothesis:  Lactating women who participate in the 16-week training (including 
3 days of resistance training and 3 days of aerobic training per week) program will 
experience decreases in total body fat percentage and increased lean body mass as 
compared to sedentary controls, and will have increased muscular strength and 
cardiovascular capacity as compared to sedentary controls. 
Specific Aim #4: To determine the effects of dietary intake on BMD and bone 
turnover in lactating women. 
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 Hypothesis:  Calcium, protein, and energy intake of lactating women will have no 
significant effect on BMD.   
 Hypothesis:  Higher calcium intake along with exercise will lead to decreased 
bone mineral loss and a decrease in bone turnover. 
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CHAPTER I 
MATERNAL DIET AND EXERCISE: EFFECTS ON LONG-CHAIN 
POLYUNSATURATED FATTY ACID CONCENTRATIONS IN BREAST MILK 
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REVIEW OF LITERATURE 
Dietary Sources, Metabolism, and Functions of n-3 and n-6 Fatty Acids 
 Before the increase in consumption of trans fatty acids and saturated fats in the 
human diet, n-6 and n-3 fatty acid intakes were at a balance, with a ratio of approximately 
1:1.  In recent years, the ratio has grown closer to 25:1 (1), leading to a deficiency of n-3 
fatty acids in Western diets.  According to Simopoulous (1), the optimal intake of 
linolenic acid (LNA) is 800-1100 mg/day, and the optimal intake of eicosapentaenoic 
acid (EPA) and docosahexaenoic acid (DHA) is 300-400 mg/day. The latest dietary 
reference intake (DRI) for linoleic acid (LA) for adult females aged 19-50 is 12 g/d (13 
g/d for lactating women), and for LNA the recommendation is 1.1 g/d for this same 
population (1.3 g/d for lactating women) (2).  The current dietary intake recommendation 
for the ratio of n-6 and n-3 fatty acids is 2-5:1 (3, 4, 5), while the World Health 
Organization recommends a ratio of 5-10:1 (6).   
Fatty acids in the diet come from a variety of sources.  LA is found in the seeds of 
most plants (excluding coconut, cocoa, and palm).  LNA can be obtained through the 
chloroplast of green leafy vegetables, as well as from flax seed and English walnuts.  
DHA and EPA are mostly found in fatty fish, fish oils, and some algae and ferns, whereas 
arachidonic acid (AA) can be found in the phospholipids of grain-fed animals (1). 
The fatty acids DHA and AA, as well as the ratio of the total n-6 to total n-3 fatty 
acids, are of the greatest importance to ensure optimal fatty acid status.  If the ratio of n-6 
to n-3 is too high, as is the case in most western diets, an interference in the conversion of 
the parent fatty acids into DHA and AA can result.  In most cases, an increased level of 
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LA is seen, which preferentially uses the Δ6 desaturase enzyme to produce AA.  This 
leads to a decreased conversion of DHA from LNA, with a subsequent increase in AA, 
and potentially a decrease in DHA status. 
While fatty acid deficiency is rare, it does occur.  Fatty acid deficiency was first 
discovered in studies using fat-free milk infant formulas and fat-free parenteral adult 
formulas (7, 8, 9).  Deficiency symptoms including skin problems and visual problems 
were reversed upon addition of LA to the diet.  These early studies (7, 8, 9) were 
groundbreaking in identifying deficiencies and those at risk. 
Fatty acids have multiple functions in the human body.  Fatty acids can be a 
source of energy, both for support of physical activity as well as for basal energy needs.  
Fatty acids are also necessary for growth and for development and maintenance of neural 
and visual processes.  When fatty acids are used for energy, they undergo β-oxidation, a 
process in which the fatty acid chain is broken down in a stepwise manner to produce 
acetyl groups, which then move into the mitochondria, through the Krebs cycle, and into 
the electron transport chain to produce the ultimate energy source, adenosine triphosphate 
(ATP).  This process is constantly taking place, but is especially active during times of 
fasting, or in the post-absorptive state, in which the carbohydrate status of the individual 
is low and energy needs to be maintained.  In this case, fat oxidation will be upregulated 
to meet energy needs.  In addition to the maintenance of basal energy needs, growth also 
needs to be supported and maintained. 
It is well documented that the n-6 and n-3 fatty acids, specifically DHA and AA, 
accumulate in the brain and retina of infants (10, 11).  This accumulation is important for 
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the neural and visual development of the infant, as well as for eicosanoid formation.  
Evidence also suggests that infants are able to convert LNA to DHA and LA to AA (12). 
Fatty acids can come from multiple dietary sources, and can be used for many 
metabolic processes.  These processes include energy production, growth, immune 
health, and brain and retinal development.  Deficiency is rare, but has distinct, yet 
reversible symptoms.  Fatty acids need to be present in the body, not only to promote 
growth and development, but also to prevent illness and disease. 
 
Factors Affecting Concentration of n-3 and n-6 Fatty Acids in Human Milk 
 Fatty acid levels in human milk are typically studied in order to determine the 
appropriate amount of the fatty acids needed for infant formula.  While human milk is 
known to be the perfect food for an infant, it is sometimes debated as to what is necessary 
for those infants who are fed infant formula, or who are premature and may need extra 
nourishment in those first few months.  N-3 fatty acids have been found to play a key role 
in the development of infants, including both neural and visual development. 
The fatty acid content of human milk is influenced to the greatest extent by time 
postpartum, gestational age, parity, presence of disease, and diet.  Maternal diet appears 
to have the greatest effect (13, 14, 15).  Francois et al. (16) fed fourteen lactating women 
six different test fat meals and measured the fatty acid transfer to breast milk over 
multiple time points.  Most of the fatty acids appeared in the breast milk at the first 
collection (6 hours after feeding), reached the highest levels between 10 and 24 hr, and 
remained elevated for up to 3 days.  Interestingly, EPA and DHA remained elevated 
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longer than any other fatty acids, and reached their peak at a later time point.  The 
researchers of this study theorize that this may be due to EPA and DHA having smaller 
pools (except the DHA in the brain) in the body, leading to less availability for energy 
needs.  Similarly, the fatty acids with larger pools appear to be less affected by dietary 
intake (16).  Supplementation of a lactating mother with DHA increases the DHA content 
of her breast milk.  Lactating women were given either 200 mg DHA per day, or a 
placebo, for two weeks.  Supplemented women had a 2-fold increase in DHA in their 
breast milk on day 14.  Infant outcomes, however, were not documented in the study 
(17).  Results of this study by Fidler et al. (17), agree with results found by Makrides et 
al. (18) in which 20% of supplemented DHA was transferred to breast milk, independent 
of amount of supplementation.  Del Prado et al. (19) fed ten lactating women [13C] 
linoleic acid based on kilogram body weight, in a controlled diet, at five months 
postpartum to determine LA and AA concentrations in breast milk.  Only about 16% of 
the labeled LA was recovered at 72 hours, and a minimal amount (0.01%) of labeled AA, 
product of desaturation of labeled LA, was found in the milk.  LA and AA were 
measured in the milk and were approximately 32.8% and 11.8%, respectively.  Del Prado 
et al. conclude that a very small amount of milk AA comes from the conversion of LA or 
from direct absorption in the intestine.  It is suggested that most milk LA and AA come 
from maternal body stores (19). 
Martin et al. (20) examined the breast milk (colostrum and mature milk) and 
white adipose tissue in lactating women at day five and day 30 postpartum.  These 
researchers found that as the duration of lactation increased the proportion of the long 
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chain polyunsaturated fatty acids (LCPUFA) in white adipose tissue did not change.  LA 
in the adipose was higher, and LNA was lower, in the adipose as compared to colostrum 
or mature milk.  A positive correlation was found in the levels of LA, as well as the LNA: 
LA ratio, in the adipose tissue as compared to colostrum and mature milk. Even though 
LNA decreases in human milk as lactation progresses, the infant will actually be 
receiving a greater amount of the fatty acids in later lactation due to the increased volume 
and fat content of the milk.  These researchers suggest that a greater mobilization of fatty 
acids from adipose tissue occurs in early lactation (20).  The average American diet has 
more n-6 fatty acids as compared to n-3 fatty acids, as previously discussed.  This also 
directly relates to the ratio in breast milk.  The infant will receive much more LA than 
LNA, which may subsequently result in a deficiency of DHA produced due to the 
competition of the desaturase enzymes. 
The relationship between maternal diet and the lipid content of milk has been 
somewhat complicated to determine, however, it does appear that there is a connection 
between maternal body composition and the lipid content of milk (21).  Lipids that are 
incorporated into human milk are derived from lipids in the circulation as well as from 
the ability of the mammary gland epithelial cells to produce free fatty acids (FFA) and 
triglycerides (TG).  The lipids in the maternal circulation can come from numerous 
sources, which include the maternal diet leading to intestinal absorption and subsequent 
release into circulation, endogenous liver synthesis, or mobilization of adipose tissue 
stores (22, 23, 24).  In the post-absorptive state, the lipids are derived mostly from 
adipose tissue stores, which then undergo lipolysis, forming FFA, which pass through the 
 
 
10 
 
circulation bound to albumin, into the mammary gland.  The portion of milk lipid that is 
derived from the liver is in the very low-density lipoproteins (VLDL) form.  To 
determine the sources of the FFA found in the milk produced, it is necessary to separate 
the FFA by chain length.  The medium chain FA (C10:0-C16:0) are those that have been 
synthesized by the mammary gland (14), and the FA that were originally in the 
circulation are of longer chain length (C16:0 and longer).   
In a recent study, ten lactating women were fed 2.5 mg of [13C] LA per kilogram 
body weight at five months postpartum.  LA was measured in serum, milk, and breath, 
and the women were separated into groups based on body mass index (BMI; <22.5 or 
>23.5).  Women in the higher BMI group exhaled more labeled CO2 than the leaner 
group.  While there was no significant difference in total transfer of LA into milk, the 
leaner group transferred the LA into the milk at a slower rate.  Villalpando et al. suggest 
that a large portion of the LA is stored in maternal fat tissue and is released slowly into 
the maternal circulation (25). 
 Caloric deficit may be an effective method to increase the mobilization of fatty 
acids from the adipose tissue to the mammary gland.  Researchers have found that when 
caloric restriction is imposed on the body, the body will mobilize a greater amount of 
adipose tissue for fuel for the body.  This mobilization may lead to increased FFA in the 
plasma.  However, this data is contradictory to the findings by Hagve et al. (26).  These 
researchers found that in the serum of male subjects undergoing a 4-week weight loss 
program, the PUFA (polyunsaturated fatty acid) levels remained constant, except for a 
significant decrease in LA.  If this phenomenon is correct and weight loss leads to a 
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decrease in LA, this may have beneficial effects in terms of lowering the LA to LNA 
ratio.  A study by Bener et al. (27) found that during the observed Muslim holy month of 
Ramadan, in which participants fasted from sunrise to sunset, no difference was observed 
in the lipid concentration of breast milk obtained from mothers while fasting and again 
after their fast was completed.  These observed results may have been noted because 
although fewer meals were consumed each day by the subjects, each individual meal had 
a higher nutrient and caloric density.   
 Fatty acids in human milk are affected by multiple factors, with maternal diet, 
metabolism, and storage being the most influential.  Caloric intake may also determine 
the fatty acid content of human milk.  Determining the exact role of these maternal 
factors, along with other confounding factors, such as maternal exercise, will help to 
clarify the mechanisms that regulate levels of fatty acids in human milk. 
 
Fatty acids and Infant Development 
One of the most critical times for the development of a human is that spent as a 
fetus and the first few months of life.  While the environment in utero is crucial to the 
survival and development of the fetus, an optimal atmosphere needs to be available to the 
infant during its first year of life to ensure that the infant develops to the best of its 
potential.  In the first years of life, an infant is exposed to physical, social, and mental 
stimulation.  Among these stimuli, the infant requires proper nutrition in order to grow 
and develop, as well as to remain free from disease and illness.  Breast milk provides this 
nourishment in a way that no infant formula can duplicate.  There are over 200 
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compounds in breast milk, many of which have a yet unidentified function.  However, 
many of these compounds have been determined to be essential in providing nutrients, 
immune factors, and developmental aides to the infant.  While infant formula does 
provide adequate nutrients for the health of the infant, it does not contain the immune 
factors, which provide a defense system for the infant.  At this point in time, only a few 
infant formulas in the US contain the specific fatty acids DHA and AA, which are critical 
for the neural and visual development of the infant.  Other available formulas contain the 
precursors to the above fatty acids, which are LNA and LA, respectively.  Infants are able 
to convert these precursors to DHA and AA (12, 28), but the extent to which this occurs 
is not fully known, and may not be sufficient to support the developmental needs of the 
formula fed infant.  Breast milk contains DHA and AA, and provides these nutrients 
directly to the infant.  A debate continues concerning whether infant formula should be 
supplemented with these fatty acids, which types of fatty acids, and in what amounts they 
should be added. 
The digestion, absorption, and transport of nutrients differ in breast milk as 
compared to formula.  Bile-salt stimulated lipase in breast milk enhances the digestion of 
LCPUFA.  The fatty acids will be digested and absorbed in infants fed supplemented 
formula, but the difference in absorption of formula and breast milk may be substantial.  
This may complicate the research, as it may be difficult to determine the proper levels to 
be added to formula.  Simply mimicking breast milk may not be adequate.  The lack of 
bile-salt stimulated lipase in the formula will decrease the absorption of the fatty acids in 
the formula fed infant. 
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The two essential fatty acids are LA and LNA, and DHA and AA are known to be 
necessary for proper neural and visual development in infants.  These fatty acids are not 
produced by the human body; therefore, they must be obtained from the diet.  Once 
ingested, LA can be converted into AA and LNA can be converted into DHA and EPA, 
most of which occurs in the liver.  Specifically, this biosynthesis, as well as the 
incorporation of the unsaturated fatty acids into the phospholipid membranes occurs in 
the endoplasmic reticulum of the cells.  In a review by Innis et al. (29), it was found, 
from comparing and contrasting multiple studies, that both term and preterm infants are 
capable of synthesizing AA and DHA from LA and LNA, respectively, dependent on the 
amounts available in the diet.  Interestingly, it has been assumed that preterm infants have 
a lower conversion of LA and LNA; however, the studies reviewed by Innis et al. (29) 
showed no difference between term and preterm infants in their ability for conversion.  
Again, dietary intake of the mother was a determining factor. 
The nervous system, namely brain tissue, of the infant develops to the greatest 
extent during the third trimester of pregnancy and in the first few weeks of life.  DHA 
and AA are essential for the development of neural tissue.  DHA also plays a key role in 
the development of the retina. As development of the fetus advances, the amount of DHA 
in the retina increases (30).  Because DHA, AA, and EPA compete for the desaturase 
enzymes, Δ-5 and Δ-6, the available ratio of these fatty acids needs to be well controlled.  
High levels of AA in the diet may lead to a reduction in the DHA and EPA in tissues, as 
well as in plasma and breast milk, while the opposite is true for high levels of DHA and 
EPA in the reduction of AA (31, 32).  Therefore, the recommendation for the ratio of n-6 
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to n-3 in infant formula has been set at 5:1 to 15:1 by the European Society of Pediatric 
Gastroenterology and Nutrition (33).  No differences were found between visual acuity or 
rate of growth in infants fed either a ratio of 5:1 or 10:1.  This showed that the lower ratio 
had no negative effect on the infants.  The authors also found that while the ratio of n-6 to 
n-3 fatty acids decreased, no decrease in the plasma AA occurred.  However, it is 
important to note that the reference breast-fed group of infants had higher DHA and AA 
and a lower plasma LA to LNA ratio, when compared to both formula fed test groups 
(34). 
A group of infants that were supplemented with infant formula containing either 
DHA only, DHA and AA, or a control formula containing no DHA or AA, from birth 
until 17 weeks of age, were followed up at 18 months.  Compared to the control group of 
infants, the DHA and AA supplemented group had higher scores on the Mental 
Development Index (MDI) portion of the Bayley Scales of Infant Development –II 
(BSID-II), and both supplemented groups scored higher than the control group on the 
cognitive and motor subtests of the MDI.  The infants were also studied at four and 
twelve months of age, and correlations were seen between red blood cell and plasma 
DHA and MDI scores at 18 months of age, suggesting a relationship between early 
dietary intake of DHA and MDI performance (35). 
Retinal development is crucial in the first months of life, and DHA is the critical 
element for proper visual development of the infants.  The rod portion of the retina is 
comprised of about 50% n-3 PUFA, of which DHA is the primary component.  While the 
mechanism through which the n-3 fatty acids aid in the vision process has not been 
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completely elucidated, when DHA is deficient, vision is impaired.  The central nervous 
system has ways of conserving fatty acids, and in some studies, researchers have been 
able to induce deficiencies in pregnant and nursing rats.  During pregnancy and lactation, 
the largest changes in DHA in the retina were seen in deficient female rats (36).  The eye 
itself is capable of producing DHA from LNA and 22:5n-3 (37).  This conservation and 
production by the retina are only some of the mechanisms that are necessary to maintain 
the DHA in the retina.   
Uauy et al. (38) suggest that the n-3 fatty acids, in addition to DHA, are necessary 
for the optimal visual development of infants, as well as for normal sleep-wake cycles 
and heart rate rhythms.  Infants fed a diet void of essential fatty acids have major 
decreases in visual performance, which can be reversed through n-3 fatty acid 
supplementation.  This review looked at numerous studies, and concluded that too many 
methodological, sampling, supplementation, and analytical differences exist between 
studies to come to any clear conclusions.  It has been suggested that n-3 polyunsaturated 
fatty acids should be regarded as provisionally essential for infants (38). 
Early studies indicated reduced growth in infants fed formula supplemented with 
DHA only.  However, consideration needs to be given to the improper balance of the 
added fatty acids, and the role they have in hindering infant growth.  If the ratio of added 
fatty acids is inappropriate, infant growth may be adversely affected.  This could be 
remedied by adding both AA and DHA at appropriate levels.  High levels of DHA and 
EPA can compete with AA, and subsequently reduce AA levels, with EPA having a 
greater effect.   
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Birch et al. (39) studied full-term infants who were breast fed for the first 6 weeks 
of life, and then randomized to either a control formula or a supplemented formula.  The 
supplemented infants had better VEP (visual evoked potential) acuity at 17, 26, and 52 
weeks of age, and had better stereoacuity at 17 weeks of age.  The infants experienced no 
difference in growth between the groups.  The results of this study suggest that the need 
for AA and DHA for the visual development of infants extends beyond the first 6 weeks 
of life. 
When all of the data from the numerous studies are analyzed, and the current 
knowledge of the fatty acid needs for optimal health and development are combined, 
adequate information is still lacking.  No strong, irrefutable indicators of infant 
development have been identified.  While growth and vision can be measured with 
relative accuracy, biochemical markers (i.e. plasma level) that definitively relate to the 
growth or vision have not been discovered, although some correlations between plasma 
and red blood cell DHA and AA have been related to vision tests in one study (39).  Even 
within the vision tests themselves, there is a lack of complete accuracy, and many 
researchers disagree about which is the most appropriate test.   
The wide variations in developmental results of supplementation studies between 
breastfed and formula fed diets are due to many factors.  These factors include different 
amounts of LNA, AA, and DHA in the formulas, other differences in formula 
composition, duration of formula feeding, sample size, outcomes and tests measured, as 
well as genetic and socioeconomic influence on outcomes (40).  Infant intelligence has so 
many confounding factors that a study would require such specific and limiting criteria, 
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relating to inclusion/exclusion factors, that a large enough sample could never be 
obtained, and the study would take too many years to complete.  However, a more 
detailed and prolonged study may be necessary.  This question of fatty acid intake and 
infant development has not yet been answered, but it is known that breastmilk is the best 
nourishment for the infant.  The many components of breast milk that are yet 
undiscovered, will only shed more light of the subject.  For some researchers to say that 
there is no advantage to breastfeeding (40), even though they were only speaking in terms 
of fatty acid supplementation, contradicts the national goals to promote breastfeeding.  
Much more research needs to be conducted to conclusively determine the safety and 
amounts of supplementation necessary to provide proper nutrition to formula fed infants.  
Breast milk should be the model for the production of formula.  Substances which cannot 
be mimicked in formula may cause tremendous differences in digestion, absorption, and 
transport of the fatty acids, and other compounds.  If more research is conducted, safe 
supplementation levels determined, and effectiveness further evaluated, the supplemented 
infant formula may be a viable alternative to human milk, but it will never be the 
“perfect” food for the infant. 
 
Fatty Acids and Exercise 
The importance of exercise to the overall health of an individual is generally well 
accepted.  However, for women who have recently had a baby and are exclusively 
breastfeeding their infant, the safety of exercise has been questioned.  Studies have 
shown that not only is it safe for women to exercise moderately while breastfeeding, but 
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exercise will actually benefit the mother.  These benefits include increased cardiovascular 
fitness levels, as well as a decrease in body fat percentage.  Lovelady et al. (40) also 
found a significant decrease in abdominal skinfold thickness in lactating women who 
were undergoing a moderate exercise program.  Plasma lipids, including TG, total 
cholesterol (TC), and low-density lipoproteins (LDL) decreased over the study’s 12-week 
period in both the exercise and the control groups.  At the same time, high-density 
lipoproteins (HDL) increased in the exercise group while declining in the sedentary group 
(41). 
Borsheim et al. studied eight healthy males who underwent a 90-minute exercise 
session and 90-minute rest session.  After the acute exercise bout, plasma FFA 
concentration increased, and remained elevated for an extended period of time.  LA 
increased significantly in the exercise group when compared to the rest group.  Exercise 
decreased AA percentages in the exercise group as compared to the rest group.  The data 
appears to show an increase in FFA mobilization from VLDL and a decreased plasma TG 
concentration (42).  Oscai et al. (43) report that exercise training results in an increase in 
plasma lipoprotein lipase (LPL) activity, leading to greater clearance of TG from the 
plasma.  This mobilization may be important to replace the TG used during exercise.  The 
results of these studies suggest an increase in fatty acid mobilization as a result of 
exercise. 
Exercise leads to the mobilization of fatty acids from the adipose tissue 
triglycerides.  Exercise at intensities between 25% and 65% VO2 max leads to a 5-10 fold 
increase in fat oxidation (44).  During exercise the release of fatty acids from adipose 
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increases three fold compared to rest (45).  In two studies by Romijn et al. (46, 47), it was 
found that exercise stimulated the liberation of fatty acids from the adipose tissue.  The 
researchers suggest that this liberation is due to the need for fatty acids as fuel for the 
skeletal muscle.  In the earlier study, the researchers found that during endurance exercise 
fatty acids are both released and oxidized from TG.   
Fatty acid mobilization is affected by the intensity of the exercise bout.  In a study 
of male volunteers who were exercised on two separate visits, once at 40% of max, and 
again at 60%, adipose tissue lipolysis was determined.  Lipolysis did not differ in the 
adipose tissue of the subjects in either session, however, post-exercise fatty acid 
mobilization was greater after the 60% session.  The abdominal subcutaneous adipose 
tissue did not differ between sessions (48).  Romijn et al. found that at an exercise 
intensity of 85% of VO2 max, plasma fatty acid oxidation was actually lower than the 
oxidation at 65% of VO2 max (46, 47).  Taken together, these studies suggest that 60-
85% of VO2 max is the optimal intensity for increased fatty acid mobilization and 
oxidation. 
Conclusion 
 Maintaining an optimal intake and ratio of LA and LNA is important for health of 
adults and children.  Fatty acids perform many functions in the human body, including 
maintenance of skin and visual health.  Exercise mobilizes fatty acids from body stores 
for energy production, both for basal needs and also to support physical activity.  Fatty 
acids are also taken up by the mammary gland and are incorporated into breast milk.  
Concentrations of fatty acids in human milk are affected by maternal factors such as time 
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postpartum, parity, and diet.  Improving maternal fatty acid status may, in turn, improve 
the fatty acid composition of breast milk, providing optimal nutrition for the 
development, especially visual and neural, of the infant. 
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ABSTRACT 
Background:  Long-chain polyunsaturated fatty acids (LCPUFA) are essential for infant 
growth and development.  The amount of long-chain PUFA in breast milk depends on 
maternal diet and body stores.  Because exercise increases mobilization and utilization of 
fatty acids, maternal activity may also influence the amount of LCPUFA in breast milk. 
Objective:  To investigate the effects of exercise on α-linolenic acid (LNA), linoleic acid 
(LA), docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and arachidonic acid 
(AA) concentrations in maternal plasma and breast milk.  In addition, to determine if 
lactating women consume adequate amounts of LCPUFA to compensate for those used 
for energy during exercise. 
Design:  LCPUFA in plasma and breast milk were measured at 12 weeks postpartum in 
exercising and sedentary women.  Dietary intake was recorded for three days.  A 
subsample of women participated in exercise and rest sessions to examine the acute 
effects of exercise on breast milk LCPUFA.   
Results:  There were no differences in dietary intake between the two groups.  Intake of 
LA was 11.05 ± 1.39 and 9.34 ± 0.97 and LNA was 0.96 ± 0.12 and 0.82 ± 0.09 
grams/day by the sedentary and exercise groups, respectively.  These amounts are close 
to the Adequate Intakes of LA and LNA for lactation (13 and 1.3 grams/day, 
respectively).  No differences were found in LCPUFA in plasma and breast milk between 
groups.  After 30 minutes of exercise, there was a trend for an increase in LA and LNA, 
with no change in DHA, EPA and AA concentrations in breast milk.    
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Applications/Conclusions:  These results suggest that women consuming adequate 
amounts of LCPUFA can exercise moderately without decreasing the LCPUFA in their 
breast milk. 
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INTRODUCTION 
 It is well established that breast milk is the optimal food for infants, providing all 
the nourishment they need to grow physically and mentally for the first six months of life 
(1, 2).  Long-chain polyunsaturated fatty acids (LCPUFA), specifically α-linolenic acid 
(LNA; 18:3n-3), linoleic acid (LA; 18:2n-6), docosahexaenoic acid (DHA; 22:6n-3), 
eicosapentaenoic acid (EPA; 20:5n-3), and arachidonic acid (AA; 20:4n-6) are some of 
the many components in human milk that promote infant growth and development. 
LNA and LA are essential fatty acids that can be desaturated and elongated into 
the longer chain fatty acids EPA, DHA, and AA, respectively.  DHA is an important 
nutrient in breast milk that is crucial for neural and visual development of the infant (3).  
During lactation, 70-80 mg of DHA is utilized per day for breast milk production (4).  
AA has also been shown to affect infant growth and development (5). 
Intake of LCPUFA by the breast fed infant is dependent on maternal diet, body fat 
stores, and possibly activity level.  Dietary fatty acids of lactating women can be utilized 
in three ways: 1) stored in the adipose tissue, 2) transferred to the mammary gland for 
incorporation into milk, and/or 3) used for energy, especially during exercise.  Exercise 
mobilizes fatty acids from body stores for energy.  Increased metabolism during exercise 
may lead to a decrease in concentrations of LCPUFA available for incorporation into 
breast milk.  However, the increased loss due to oxidation of the fatty acids may be 
countered by an increase in fatty acid mobilization from adipose stores.  This 
phenomenon has not been investigated in lactating women.   
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Current recommendations of the Centers for Disease Control and Prevention and 
the American College of Sports Medicine (6) are to exercise moderately 30 minutes per 
day, every day of the week, whereas the Institute of Medicine (7) recommends 
incorporating 60 minutes of moderate exercise per day to achieve optimal health benefits.  
In addition, the American Academy of Pediatrics and the American Dietetic Association 
recommend that all women breastfeed their infants during the first year of life (1, 2).  
However, there is a paucity of research on the effects of exercise by lactating women on 
the composition of their breast milk. Therefore, the purpose of this study was to 
investigate the effects of chronic and acute exercise on plasma and breast milk LCPUFA.  
Another objective was to determine if breastfeeding women consume adequate amounts 
of LCPUFA to compensate for those used for energy during exercise. 
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METHODS 
 
Participants 
 Healthy (absence of chronic disease), nonsmoking, exclusively breastfeeding 
women were recruited from prenatal classes and obstetricians’ offices.  Participants were 
eligible if 1) their body mass index (BMI) was between 20 and 30 kg/m2, 2) their infants’ 
birth weight was greater than 2500 grams, and 3) there were no birth complications.  
Mothers were assigned to one of two groups based on their self-reported exercise history.  
The exercise group (EG) consisted of mothers who exercised at least 30 minutes a day, 
three days per week, for the past six weeks (n=30).  Women were assigned to the 
sedentary group (SG) if they exercised once a week or less (n=23).  A subsample (n=14) 
of women from the EG completed a second study examining effects of acute exercise, in 
which subjects participated in an exercise session and a rest session.  This research study 
was approved by the Institutional Review Board of the University of North Carolina at 
Greensboro, and written, informed consent was obtained from all participants.  This 
research was conducted prior to establishment of the HIPPA guidelines. 
Experimental Design 
 This was a cross-sectional study that measured the LCPUFA concentrations in 
plasma and breast milk of sedentary and exercising lactating women at 12 (± 2) weeks 
postpartum.  Breast milk was collected by each woman on the morning of her laboratory 
measurements.  Milk (30 ml) from the first feed after 5 AM was expressed and stored in 
the subject’s home freezer until transported to the lab, where it was frozen at –80 ˚C until 
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analysis.  Blood samples were drawn and then body composition and cardiorespiratory 
fitness were measured. 
Fourteen of the exercising women returned for two more tests to determine the 
effects of acute exercise on concentrations of fatty acids in breast milk.  The women 
participated in both a rest and an exercise session, with the order of sessions randomized.  
Sessions were separated by approximately two days.  Exercise consisted of brisk walking 
or jogging at an intensity of approximately 75% of predicted maximum heart rate for 30 
minutes.  During the exercise session, breast milk was expressed before the onset of 
exercise and 10 and 60 minutes after the exercise bout.   During the rest session, milk was 
collected at the same time points, with the women resting in a seated position for the 30-
minute test period.  All milk was completely expressed with a Medela electric breast 
pump (McHenry, IL) from both breasts at each time point.   Samples were frozen at –80 
˚C until analysis. 
Dietary Analysis 
 Prior to laboratory measurements, women weighed their food and beverage intake 
on a portable digital gram scale (OHAUS, Florham Park, NJ) and recorded their 
consumption for three days.  The Food Processor Analysis Program (version 2.2, Salem, 
Oregon), along with manufacturer information, food label nutrient content information, 
and other food composition tables (8), were used for dietary analysis. 
Anthropometrics 
Weight to the nearest 0.1 kg was measured on a stationary beam balance with 
women wearing only a bathing suit.  Height was measured, using a stadiometer, to the 
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nearest 0.1 cm.  Body composition was measured by hydrostatic weighing.  Body density 
and percent body fat were calculated using the equations of Brozek et al. (9). 
Cardiorespiratory Fitness Level 
To assess the cardiorespiratory fitness level of the participants, a submaximal 
graded treadmill test was used (10).  Women wore a heart rate monitor (Polar, Inc., 
Woodbury, NY).  Heart rate and perceived exertion were measured and recorded every 
minute for the duration of the test.  Participants exercised until their heart rate reached 
85% of their predicted maximal heart rate, and predicted oxygen consumption (VO2) was 
determined using the formulas of the American College of Sports Medicine (10).  Linear 
regression was used to determine the subject’s predicted VO2max using heart rate as the 
independent variable and predicted VO2 as the dependent variable. 
Plasma and Breast Milk Fatty Acid Analysis 
Blood was drawn by venipuncture from an antecubital vein by a trained 
phlebotomist, after a 12-hour fast.  The plasma layer was separated and stored at -80˚C 
until analyzed for fatty acid content.  Plasma fatty acids were extracted by an adapted 
method of Bligh and Dyer (11).  Breast milk was extracted using a modified Folch 
procedure as detailed by Bitman et al. (12).  The fatty acid profiles of plasma and breast 
milk were determined by a gas chromatograph (GC) (5890 Gas Chromatograph, Hewlett 
Packard, Avondale, PA).  Plasma was collected from a subsample of 38 (SG, n=14; EG, 
n=24) women, because measurement of plasma FA was started after 15 women had 
already completed the study of breast milk fatty acids.  Milk was not collected from one 
participant in the SG due to laboratory error. 
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Statistical Analysis 
 SPSS-PC (Version 10.0, SPSS, Chicago, IL) statistical software was used for all 
data analysis. Student’s t test was used to assess differences between experimental 
groups.  Repeated measures ANOVA was used to determine if breast milk LCPUFA 
concentrations changed during exercise or rest sessions.  Pearson’s correlations were 
identified for relationships between breast milk fatty acids and diet, plasma, parity, and 
percent body fat.  Multiple linear regression analysis was used to predict concentrations 
of breast milk fatty acids from the above variables.  Statistical significance was set at 
P<0.05.   
 
 
36 
 
RESULTS 
There were no significant differences between groups in characteristics of 
participants, except that exercising women exhibited a higher level of cardiorespiratory 
fitness (Table 1).  They reported exercising an average of 47 minutes per day, four days 
per week.  The majority of the women walked briskly and/or participated in aerobic 
exercise classes.  Their average fitness level was in the 80th percentile, according to 
values given by the American College of Sports Medicine (10) for cardiorespiratory 
fitness.  The sedentary women had an average fitness level in the 40th percentile.   
There were no differences in percent body fat (Table 1) or dietary intake (Table 2) 
between the two groups; except that arachidonic acid intake was significantly higher in 
the SG.  Both groups consumed a diet of approximately 55% carbohydrates, 15% protein, 
and 30% fat; and the ratio of LA to LNA was approximately 11.5:1. 
There were no significant differences in the concentrations of the LCPUFA in the 
breast milk (Table 3) of exercising and sedentary lactating women.  Breast milk and 
plasma of the subgroup (n=38) were also not significantly different between groups (data 
not shown).  Due to the lack of difference between groups, the data from all subjects were 
pooled together for further analysis.  Breast milk AA and dietary AA were correlated 
(r=0.29, p=0.04); however, there were no correlations between breast milk and dietary 
intake of the other LCPUFA’s.  Plasma LA and AA were significantly correlated with 
milk LA (r=0.33, p=0.04) and AA (r=0.45, p=0.005), respectively.  There was no 
correlation between parity or percent body fat and breast milk fatty acid concentrations in 
this group.  When these were controlled for, there were still no significant differences in 
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dietary fatty acid concentrations between groups. In multiple regression analysis, dietary 
intake, parity, and percent body fat did not predict fatty acid concentrations in breast 
milk.  
Characteristics of the subsample who participated in the second study were 
similar to the characteristics of all the women in the EG, shown in Table 1.  Between 
session changes over time were noted (Figure 1) for LA and LNA; however, these 
changes were not significant (LA, p=0.18; LNA, p=0.23).  During the exercise session, 
LA increased from time 0 to 60, but in the rest session, LA decreased from time 0 to 60.  
Similarly, LNA increased in the exercise session from time 0 to 60.  However, in the rest 
session, LNA increased from time 0 to 10, but decreased from time 10 to 60, with time 60 
falling to a concentration lower than the initial measurement (Figure 1).  There were no 
significant differences in changes over time for AA, EPA, or DHA (data not shown).  
Interestingly, percent body fat was significantly correlated with concentrations of LA in 
milk at time 60 after the exercise session (r= 0.62, p= 0.02) and with concentrations of 
LNA in milk at time 10 (r=0.53, p= 0.04) and time 60 (r= 0.77, p= 0.001) after the 
exercise session.  There were no significant correlations between percent body fat and 
milk LCPUFA concentrations during the rest sessions.   
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DISCUSSION 
 
In this study, dietary intake and exercise did not significantly affect the plasma 
and breast milk of lactating women.  However, there was a trend towards an increase in 
LA and LNA after an acute exercise bout.  With the exception of AA intake, there were 
no differences in the diets of the women in this study.  On average, these women ate diets 
sufficient in calories, protein, and fat, and were similar to dietary intakes of lactating 
women reported by other researchers (13, 14).  It is possible that the observation of no 
effect of diet or exercise on the LCPUFA concentrations (except AA) in breast milk was 
because there was insufficient variation in intakes among the women.     
The optimal ratio of n-6 to n-3 fatty acids has not been established; however, 
researchers suggest a ratio of less than 10:1 (15).  This ratio is estimated to be 25:1 in 
American diets due to increased consumption of processed foods in place of natural foods 
(16).  Women in the current study consumed diets with an n-6/n-3 ratio at about 11.5:1, 
which is better than the reported national average.  The recommended Adequate Intakes 
of LA and LNA for lactation are 13 grams/day and 1.3 grams/day, respectively (7).  Diets 
of breastfeeding mothers in this study were close to these recommendations (Table 2).  
Conversion of LNA into DHA and EPA is quite inefficient (15); therefore, in addition to 
consuming adequate amounts of LA and LNA, breastfeeding women should make efforts 
to consume adequate amounts of DHA and EPA.  These results suggest that active, 
breastfeeding women are able to meet the new dietary recommendations for LA and 
LNA; however, specific recommendations are not yet available for DHA, EPA, and AA.   
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Current recommendations for LA and LNA for infants aged 0-6 months are 4.4 
and 0.5 g/day, respectively (7).  Based on the recommended total fat intake of 31 g/day 
for this age group (7), the percent of total fat coming from the individual fatty acids (LA 
and LNA) can be calculated as 14.2% and 1.6%, respectively.  Average concentrations of 
LA and LNA in our breast milk samples were similar to these recommendations (Table 
3), indicating that the women in this study were able to provide sufficient LA and LNA 
for their infants. 
Concentrations of fatty acids were similar to those reported by others in breast 
milk (17) and plasma (18).   Only dietary and breast milk AA concentrations were 
significantly related in our study.  However, isotope tracer studies indicate that maternal 
body stores, rather than diet, are the major source of breast milk fatty acids, suggesting 
that dietary fatty acids are first stored in the body and later mobilized for incorporation 
into breast milk (19).     In addition, concentrations of LCPUFA in breast milk were 
lower than concentrations of LCPUFA in plasma, with the exception of LNA, which was 
slightly higher in breast milk than in plasma.  This suggests that the availability of 
LCPUFA in the plasma is not a limiting factor for concentrations in breast milk.   
Fatty acid concentrations decrease as parity increases (20).  The observation of no 
effect of parity on concentrations of fatty acids in breast milk may be, in part, due to the 
limited range of parity in this group.  Most women had a parity of 1 (n=18) or 2 (n=23), 
with only 13 women having a parity of 3 or greater.  While breast milk fatty acid 
concentrations did decrease as parity increased, this relationship was not significant. 
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Exercise leads to the mobilization of fatty acids from the adipose tissue 
triacylglycerol; plasma fatty acid concentrations increase three fold compared to rest (21).  
We observed that 30 minutes of moderate exercise increased concentrations of LA and 
LNA in breast milk; however, the increase was not significant.  Borsheim et al. (22) 
observed a similar increase in LA in the plasma of exercising as compared to resting men, 
and Mougios et al. (23) reported that male handball players had an increase in plasma LA 
after two 30-minute playing sessions.  However, we observed no effect of exercise on 
concentrations of AA in breast milk, in contrast to the decrease in plasma AA reported by 
Borsheim (22).   
The observation of no exercise effect on breast milk DHA may be related to DHA 
being one of the fatty acids stored in small quantities in the human body.  And during 
lactation, storage concentrations are much lower than normal (4).  Therefore, there may 
be much lower amounts of DHA mobilized during exercise, as compared to LA and 
LNA.  Plasma lipid fractions also contain very little EPA and AA.  Turnover of these free 
fatty acids is quite rapid in the time between meals in order to provide tissues with 
nourishment (24).   
Since exercise stimulated lipid mobilization can continue for an extended period 
of time after cessation of exercise (22), fatty acids may have been transferred to breast 
milk from plasma after the 60-minute measurement point.  In our sample, there was a 
trend towards an increase in the concentrations of LA and LNA in the breast milk from 
10 to 60 minutes after exercise.  This increase may have been higher if we had continued 
our measurements beyond 60 minutes.  These results suggest that instead of experiencing 
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a decrease in breast milk LA and LNA concentrations after exercise, women may, in fact, 
have increased concentrations of LA and LNA in their breast milk.   
The significant relationship between percent body fat and concentrations of LA 
and LNA 60 minutes after the exercise session suggests a greater mobilization of LA and 
LNA during exercise in women who have a higher percent body fat.  This is likely due to 
a greater availability of fat for mobilization.  The trend towards an increase in 
concentrations of LA and LNA after exercise indicates that LA and LNA may actually 
increase in breast milk after exercise, especially among women with adequate body fat 
stores.  This may not be true for women who are underweight.   
Moderate exercise is not only safe during lactation, but also improves the 
cardiorespiratory fitness levels of postpartum women, and provides many other health 
benefits (25-27).  We have previously reported no effect of exercise on breast milk 
concentrations of macronutrients (25, 27), vitamin B6 (28), or immunological compounds 
(29).  This study found no effect of exercise on the LCPUFA concentrations in breast 
milk.  Therefore, a lactating woman with adequate body fat stores, and consuming a diet 
sufficient in calories and essential fatty acids (including total fatty acid intake and LA to 
LNA ratio), can perform moderate exercise without decreasing, and potentially 
increasing, the concentrations of LCPUFA in her breast milk.
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TABLE 1.  Characteristics of Participants*    
 
Characteristic Sedentary Group   Exercising Group
  
 (n=23)   (n=30) 
 
Age (yrs) 31.5 ± 1.0   31.5 ± 0.6 
 
Height (cm)      163.1 ± 1.1       164.6 ± 1.2 
 
Weight (kg) 66.0 ± 1.6   64.0 ± 1.5 
 
Body Mass Index (kg/m2) 24.9 ± 0.7  23.6 ± 0.5 
 
% Body Fat 28.0 ± 1.4   25.5 ± 1.1 
 
Predicted maximal oxygen consumption (O2/kg/min) 32.2 ± 1.0      39.6 ± 1.0** 
 
* Values are means ± standard errors of the means. 
 
** Significantly different from sedentary group, p < 0.01 
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TABLE 2. Dietary Intake*       
 
 Sedentary Group  Exercising Group 
 
  (n=23)   (n=30) 
 
Total energy intake (kcal) 2276 ± 93  2142 ± 106 
  
 Kcal/kg body weight 35 ± 2  34 ± 2 
 
Total protein intake (grams) 85 ± 5  83 ± 3 
 
  % kcal from protein 15 ± 1  16 ± 1 
 
Total carbohydrate intake (grams) 313 ± 13  306 ± 18 
  
 % kcal from carbohydrate 55 ± 1  56 ± 2 
 
Total fat intake (grams) 80 ± 5  69 ± 5 
 
  % kcal from fat 32 ± 1   29 ± 1 
  
Fatty acid intake (grams)     
 
   18:2 n-6 (LA) 11.05 ± 1.39  9.34 ± 0.97 
 
   18:3 n-3 (LNA) 0.96 ± 0.12  0.82 ± 0.09 
 
   20:4 n-6 (AA) 0.10 ± 0.01    0.06 ± 0.01** 
 
   20:5 n-3 (EPA) 0.03 ± 0.01  0.03 ± 0.01 
 
   22:6 n-3 (DHA) 0.06 ± 0.02   0.05 ± 0.02 
 
* Values are means ± standard errors of the means. 
 
** Significantly different from sedentary group, p < 0.05 
 
LA=linoleic acid, LNA=linolenic acid, AA=arachidonic acid, EPA=eicosapentaenoic  
 
acid, DHA=docosahexaenoic acid 
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TABLE 3.  Skinfold Measurements*   
 Sedentary Group (n=23) Exercising Group (n=30) 
Triceps 23.45 ± 1.45 19.89 ± 1.02** 
20.42 ± 1.55 15.96 ± 1.12** Subscapular 
13.80 ± 0.95 11.03 ± 0.82** Midaxillary 
21.46 ± 1.39 20.33 ± 1.52   Abdominal 
13.87 ± 1.18 12.06 ± 0.89 Suprailiac 
42.53 ± 2.72 36.10 ± 2.21 Thigh 
 
* Values are means ± standard errors of the means. 
 
** Significantly different from sedentary group, p < 0.05
 
 
49 
 
 
TABLE 4.  Fatty acid Composition of Breast Milk & Plasma*   
  
 Sedentary Group   Exercising Group 
 
  (milk n=22)   (milk n=30) 
  
 (plasma n=14)   (plasma n=24) 
  
% of total fat      
 
18:2 n-6 (LA)       
 
Breast Milk 16.94 ± 0.97   14.71 ± 0.72 
 
Plasma 32.43 ± 1.46   31.38 ± 0.80 
 
18:3 n-3 (LNA)      
 
Breast Milk 1.14 ± 0.11   1.03 ± 0.09 
 
Plasma 0.97 ± 0.14  0.98 ± 0.09 
 
20:4 n-6 (AA)       
 
Breast Milk 0.41 ± 0.03  0.38 ± 0.02 
 
Plasma 6.72 ± 0.36   6.14 ± 0.21 
 
20:5 n-3 (EPA)      
 
Breast Milk 0.30 ± 0.08   0.39 ± 0.09 
 
Plasma 0.42 ± 0.05  0.54 ± 0.06 
 
22:6 n-3 (DHA)       
 
Breast Milk 0.21 ± 0.08  0.43 ± 0.09 
 
Plasma 0.92 ± 0.09   1.01 ± 0.10 
 
* Values are means ± standard errors of the means. 
 
LA=linoleic acid, LNA=linolenic acid, AA=arachidonic acid, EPA=eicosapentaenoic  
 
acid, DHA=docosahexaenoic acid 
 
 
 
 
50 
 
FIGURE 1.  Percent linoleic acid (LA) and linolenic acid (LNA) in breast milk of 
women before (Time 0) and after (Time 10 and Time 60) the 30-minute rest session or 
exercise session.  Values are means ± SEM.  LA concentration decreased during rest and 
increased during exercise.  Changes were similar with LNA concentrations.  However, 
these changes were not significant (RMANOVA). 
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CHAPTER II 
 
THE EFFECTS OF DIET AND EXERCISE ON BODY COMPOSITION, BONE 
MINERAL DENSITY AND BONE TURNOVER MARKERS DURING LACTATION 
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REVIEW OF LITERATURE 
Bone Density Changes During Lactation 
During lactation, maternal bone density decreases due to hormonal changes and 
increased calcium losses to breast milk.  Bone losses during lactation average from 3 to 
5%, ranging up to 10% in some women (1).  Reductions in bone mineral density (BMD) 
occur mostly in the spine and hip regions (2), due to a greater percentage of trabecular 
bone.  Bone density losses are the greatest in the first 3-5 months of lactation (1-3% per 
month), and evidence indicates that in later lactation and early weaning mineral stores 
may be somewhat replenished (3, 4).  At 6 months postpartum, lumbar spine BMD was 
decreased in lactating women (-6.5 %) as compared to BMD measurements at 2 days 
postpartum (5).  Lactating women had more significant lumbar spine and total bone 
losses than non-lactating controls at 6 months postpartum.  After weaning, lactating 
women showed greater bone gains than the non-lactating controls (6).   
The majority of BMD losses appear to occur in the first 3-5 months of lactation, 
but recovery to normal BMD levels does not take place until lactation ceases.  It is 
important to note that BMD does not always completely recover upon cessation of 
lactation.  Studies examining bone loss during lactation found that BMD levels at 5 
months post-weaning were lower than BMD levels at pre-pregnancy and delivery (4, 7, 
8).  Therefore, minimizing losses of bone density during the lactation period may 
promote quicker and more complete recovery of bone mineral density upon weaning. 
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Whether or not bone density losses in pregnancy and lactation lead to poor bone 
mineral status later in life, and possibly osteoporosis, is still somewhat controversial (9).  
A recent retrospective twin study by Paton et al., found no deleterious effect of 
pregnancy or lactation on bone mineral density later in life.  In fact, women who had 
been pregnant had higher bone density than never pregnant women, and women who 
breastfed their infants had bone densities higher than their non-breastfeeding twin 
counterparts (10).  Therefore, even though research studies are still not conclusive 
concerning the long term effects of BMD loss during lactation, improving bone density 
during lactation will benefit mothers later in life. 
Markers of Bone Turnover 
 Bone turnover is comprised of a resorption phase and a formation phase.  Some of 
the markers of bone resorption include urinary pyridinium cross links, deoxypyridinoline 
(DPD) and pyridinoline (PYD), hydroxyproline, and helicopeptide (HP).  Commonly 
used markers of bone formation include serum osteocalcin (OC) and bone-specific 
alkaline phosphatase (BAP).  In studies investigating the effects of lactation on bone 
turnover, markers are usually measured within the first few days or weeks of partuition 
(11, 12, 13) and at 6 months postpartum (11, 12).  Sowers et al. also measured bone 
markers at 2, 4, 12, and 18 months postpartum (11), while others set their endpoint 
measures at 3 months postpartum (13).  Markers of bone turnover will fluctuate over a 6 
month study period; however, based on the above studies (12, 13) it is sufficient to 
measure these markers at baseline and endpoint to assess change over time in this 
population.  This is the model for the current research study to follow. 
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 DPD is highly specific to bone and its crosslinks are found in the blood and urine 
following the breakdown of crosslinked collagen.  The crosslinks serve to strengthen the 
collagen molecules.  DPD levels in the urine indicate the degradation of mature collagen, 
as opposed to newly formed collagen.  Other measures of bone resorption (i.e. 
hydroxyproline) can be contaminated by the breakdown of this newly formed collagen, 
making DPD a more reliable and sensitive indicator of bone resorption.  Urinary DPD 
and PYD are also widely used bone resorption markers because they are not influenced 
by dietary intake (14). PYD is also one of the major crosslinks of bone collagen, 
however, it is also found in cartilage, bone, ligaments and blood vessels.  Turnover is 
much higher in bone than in cartilage, ligaments and vessels; therefore, amounts of PYD 
found in urine come primarily from bone resorption.  Currently, PYD and DPD are 
considered the best measures of bone resorption (15-20).  HP is a urinary measure of the 
helical part of the type I collagen.  HP is a relatively new assay, and has been well 
correlated to C-terminal cross-linking type I collagen, which is a well-established assay 
(21).  Type I collagen is the most prevalent protein found in the bone matrix.  When bone 
resorption occurs, type I collagen is cleaved from both the helicoidal and telopeptide 
regions.  DPD, as described above, is a measure of cross-links from the telopeptide 
region.  HP is a measure of the helicoidal region of the type I collagen, which is the major 
portion of the protein.  Assessing both the telopeptide and helicodal regions allows for 
increased understanding of bone resorption. 
Alkaline phosphatase is thought to play a role in bone mineralization, or bone 
formation, however, the specific function of the enzyme is not yet known.  There are 
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multiple isoforms of alkaline phosphatase, including bone, liver, and kidney.  In healthy 
adults, absent of liver problems, total alkaline phosphatase is comprised of 50% liver, and 
the other 50% comes from the bone.  However, there is a specific assay that detects the 
bone-specific alkaline phosphatase (BAP).  BAP is a direct product of osteoblasts.  In 
studies looking specifically at bone turnover, i.e. osteoporosis, where small changes in 
bone turnover are potentially detectable, BAP is the preferred assay.  BAP is a specific 
assay; however, as with many assays there is the potential for contamination, up to 20%, 
with liver alkaline phosphatase (22). 
Osteocalcin (OC), another marker of bone formation, is also a specific marker of 
the function of osteoblasts.  OC is a more delicate assay, in that it is rapidly degraded in 
serum.  It has also been suggested that because OC is a part of the bone matrix, some OC 
may be released during the bone resorption phase.  This may be especially true for 
individuals with a high rate of bone turnover, in which the smaller fragments of OC are 
released (22).  Keeping the disadvantages in mind, OC is still a commonly used, well-
accepted measure of bone formation.  Used along with BAP, these two indicators provide 
a good understanding of the rate of bone formation.  With the exception of HP, all of the 
above markers have been used to study the lactating population (11-13). 
Hormones and Bone Mineral Density 
 Prolactin, a hormone necessary to stimulate and maintain lactation, is 10-20 times 
higher in pregnancy as compared to the non-pregnant state.  Postpartum, prolactin levels 
gradually decline, independent of lactation.  Lactating women have prolactin levels that 
continue to be elevated (above that of non-lactating and pregnant women) if they are 
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exclusively breastfeeding until 6 months postpartum (5); however, prolactin levels also 
decrease significantly in breastfeeding women during the first 6 months postpartum.  
Basal prolactin levels are lower in multiparous mothers, as compared to primiparous 
mothers, yet, milk intake is greater in infants of multiparous mothers.  This may be due to 
an increased uptake by prolactin receptors in the mammary gland of multiparous mothers, 
leading to lower prolactin levels in serum (23).  During lactation, bone loss takes place 
due to a hyperprolactinemic and hypoestrogenic state.  Multiple hormones are involved in 
calcium homeostasis during pregnancy and lactation.  These hormones include calcitonin, 
parathyroid hormone (PTH), and 1,25- dihydroxyvitamin D (1,25D).  Calcitonin levels 
are variable during lactation, and may in fact be unaltered in some women.  PTH and 
1,25D may be necessary for serum calcium regulation, and may also be necessary for 
BMD recovery during late lactation and weaning.  Serum PTH may be slightly depressed 
in lactation and 1,25D is not elevated during lactation, but may be higher in lactating 
women as compared to non-lactating controls (3).  Parathyroid hormone-related protein 
(PTHrP) is now considered to be one of the prime regulators of calcium and bone 
metabolism during lactation (9, 24, 25), however this concept is still under investigation.  
PTHrP is produced by the lactating mammary gland, possibly due to the effects of 
prolactin.  PTHrP is secreted into both breast milk and into maternal circulation, and has 
characteristics similar to PTH.  PTHrP promotes the synthesis (via stimulation of renal 1-
α -hydroxylase activity and nephrogenous cyclic adenosine monophosphate) of 1,25D 
and the renal tubular reabsorption of calcium.  Therefore, during lactation, PTHrP may be 
the cause of increased 1,25D when PTH levels are low. 
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Laskey et al. (2) examined the role of an individual’s vitamin D-receptor 
genotype because of the interaction of genes with nutrients and the effects on calcium and 
bone metabolism during lactation.  This study, however, did not find any relationship of 
vitamin D-receptor genotype on bone area adjusted bone mineral content at any body site, 
or with maternal weight or height.   
 Growth hormone (GH) is an anabolic hormone that is produced by the pituitary 
gland and is involved in many metabolic systems.  Insulin-like growth factor-1 (IGF-1) is 
a growth-regulating, insulin-like peptide.  Together, GH and IGF-1 are key players in the 
bone remodeling system (26).  In addition, GH is known to increase milk production 
during lactation (27, 28); this effect is mediated by IGF-1 (29).  Further, GH and IGF-1 
are increased during exercise, and this increase may stimulate an increase in bone 
turnover.  The role of GH and IGF-1 on bone remodeling during lactation in women who 
are exercising proves to be an interesting investigation; however, studies are limited in 
this area of research. 
 During lactation, estrogen levels rapidly drop back to pre-pregnancy levels, or 
may even drop lower, in order to promote lactation.  Low estrogen levels can lead to 
decreased BMD, and coupled with excessive calcium losses to breast milk, can lead to 
rapid bone remodeling.  Normal bone remodeling occurs over a period of 4-8 months; 
however, during lactation the remodeling may occur within 3-4 months (25). 
According to Frost’s (30) hypothesis of mechanical usage set points, estrogen 
may be responsible for decreasing bone modeling and remodeling set points.  The set 
point is the level at which a given mechanical stress promotes bone remodeling at a level 
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to maintain current BMD.  Stressing the bones above this level will increase bone 
density, while not stressing the bones enough to reach the set point will result in bone 
loss.  During pregnancy when estrogen levels are high, the set point is lowered, and 
therefore increased mechanical stress (i.e. increased weight) above the low set point, 
should theoretically increase bone density.  When pregnancy ends, and estrogen levels 
decrease rapidly, the set point increases.  This means that bone stress needs to increase to 
levels above the new higher set point to increase BMD.  The extra weight of pregnancy 
also decreases, leading to decreased mechanical stress.  This theory would suggest that 
pregnant women experience increases in bone mineral density, but this is not commonly 
observed.  The other factors of pregnancy, including increased calcium needs by mother 
and fetus and many other hormonal changes, lead to BMD losses.  Frost’s theory possibly 
explains some of the BMD losses seen in lactation.  Decreased estrogen leads to an 
increased set point of mechanical usage.  Therefore, the lactating woman has to stress the 
bones at a level much higher than during pregnancy in order to prevent BMD losses and 
to promote BMD gains. 
Exercise and Bone Mineral Density 
Exercise, especially weight bearing exercise, has been shown to improve bone 
density.  Specific sites on the human body are exposed to greater mechanical stress on a 
regular basis; the legs have to support the body when walking and the spine has to 
constantly hold the body in an upright position.  These stresses help to maintain the BMD 
of the bones in these areas.  As suggested in Frost’s (30) theory, as body weight increases 
(i.e. during pregnancy) the mechanical stress on these specific bone regions will be 
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greater, and bone mineral density will increase.  In order to increase bone, it is necessary 
for the bone to be stressed at a level greater than that under normal conditions.  
Trabecular bone, the predominant bone in the vertebral column, responds to stress more 
rapidly than cortical bone.  In response to regular stimuli, or stress, new collagen fibers 
can be deposited, forming the new bone matrix, after approximately 8 to 12 weeks.  
Mineralization of this new bone will occur in the subsequent weeks or months (31-33), 
with the whole process totaling approximately 4-8 months.  This process may be 
upregulated to a total of 3-4 months during lactation (25).  
Weight bearing exercises are beneficial for increasing BMD in the region under 
stress.  Muscle contraction and gravity are mechanical forces that can increase bone 
mineralization when the body is exercising.  It is important to provide resistance to 
specific bone areas to produce the desired bone strengthening.  The axial skeleton needs 
proper loading through an appropriate training program.  Squats, deadlifts, high pulls, 
standing shoulder press, isometric pushups, ball bench presses and abdominal exercises 
work the core of the body, as well as some areas of the appendicular skeleton.   
Exercise and estrogen hormone replacement therapy (HRT) increased lumbar 
spine and femoral neck BMD individually and when used together in postmenopausal 
women, possibly due to decreased bone turnover (34).  Decreases in osteocalcin in 
response to HRT and HRT + exercise, but not in an exercise only group, suggests that the 
observed increases in BMD were due to a decrease in bone resorption and not an increase 
in bone formation (34).  In a recent study, women who exercised (aerobic, weight-
bearing, and weight-lifting) 3 days/week had improved femoral neck and lumbar spine 
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BMD when HRT was also used.  Improved trochanteric BMD was observed in exercising 
women using HRT as well as those not using HRT (35).  Postmenopausal women 
undergoing a one-year strength training program, half of which were currently using 
HRT, experienced improvements in BMD that were linear to amount of weight lifted 
over the year (36).  These studies suggest that exercise and HRT may have both 
individual and synergistic effects on bone mineral density in postmenopausal women. 
Effects of Exercise and Lactation on Bone Turnover Markers 
 Markers of both bone formation and bone resorption have been investigated in 
terms of their response to exercise.  In adult male soccer players with levels of activity 
ranging from 12 hours/week (premier players) to 6 hours/week (sixth league players), 
who were compared to older former players and matched controls, it was determined that 
the active players had higher OC, BAP, and carboxyterminal crosslinked telopeptide of 
type I collagen (ICTP).  Activity was positively correlated with BAP in those participants 
who exercised 6 hours per week or less; however, there was no difference in the higher 
activity levels (above 6 hours/week).  The authors suggested that bone adapts to current 
levels of exercise, with duration above the needed level not providing additional benefits 
(37).  Interestingly, a substudy of the premier athletes from the previous study was 
performed, in which these athletes underwent a 4-week rest period between two seasons 
followed by 10 active days into the second season.  During the rest period, bone 
formation markers carboxy-terminal propeptide of type I collagen (PICP) and total 
alkaline phosphatase (TAP) were decreased and resorption marker ICTP was increased.  
Upon resumption of exercise in the new season PICP increased and ICTP decreased.  
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Osteocalcin (OC) was higher in exercising athletes as compared to controls at baseline, 
and decreased after 7 days of rest, however this change was not significant (38).  Taken 
together, these two studies suggest that weight-bearing exercise (soccer playing, running, 
and jumping) provide benefits to bone.  In addition, the 6-hour threshold effect should be 
considered in the design of studies examining changes in bone turnover markers, and 
studies should not exceed this upper limit.  Further studies can also attempt to determine 
how this 6-hour activity level should be met (i.e. 3 vs. 6 sessions/wk).  Bone formation 
markers are higher and resorption markers are lower in adults who engage in aerobic 
activity on a regular basis, and when this activity ceases, bone formation decreases and 
resorption increases.  Shibata et al. (39) also found that one year of walking training 
promotes bone formation, indicated by an increase in BAP, with this effect greater in the 
group who added a jumping session each day in addition to walking.   
Resistance exercise training also provides an increase in bone formation markers 
and a decrease in bone resorption markers, with changes occurring early in the training 
program (40).  High intensity resistance exercise training increased bone formation in 
older adults (41), and aerobic training decreased bone resorption in young males (42).  It 
has been suggested that the effects of physical activity (aerobic and anaerobic) on bone 
turnover is dependent on the type of activity performed, and that anaerobic activity may 
increase overall bone turnover (42).  Changes in bone turnover are often apparent before 
changes in BMD via dual energy x-ray absorptiometry (DXA) can be noted (11). 
Postpartum, the mother’s body is readjusting bone metabolism from pregnancy.  
In late pregnancy, in order to provide minerals for the growing fetus, bone resorption is 
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very high, and bone formation is low.  In the first few months postpartum, a rapid decline 
in resorption, with a slower increase in formation, has been shown.  The resorption and 
formation will eventually balance at levels closer to pre-pregnancy (43, 44).  During 
lactation, bone formation remains low, and amenorrhea (with or without lactation) was 
associated with increased bone resorption; however, in lactation (with amenorrhea) 
resorption is even higher.  Overall bone turnover appears to be elevated with lactation 
(13). 
The effects of exercise on bone turnover markers during lactation have not been 
identified.  The overall elevation in bone turnover during lactation, or the rapid decline in 
resorption in the postpartum period, may override any effects that may be due to an 
exercise program; however, this is not yet known. 
Effect of Exercise on Bone Mineral Density during Lactation 
Little and Clapp (45) detected no effect of exercise on inhibition of bone mineral 
loss in eleven lactating women who participated in self-selected recreational exercise 
(walking, running, aerobics, step aerobics, stair machine).  Subjects in the exercise group 
had to exercise at least 3 days per week, for at least 20 minutes per session, at a minimum 
of 50% of maximal oxygen consumption.  These women were compared to non-
exercising controls.  All subjects (both exercisers and non-exercisers) presented with 
femoral neck and lumbar spine losses at 3 months postpartum.  The non-exercisers, 
however, had greater losses at the lumbar spine than the exercisers, but the difference was 
not significant.  It is suggested, by these authors, that a planned intervention, utilizing 
both resistance and aerobic exercise may provide the necessary stimulus to improve 
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BMD during lactation (45).  A successful intervention to improve bone mineral density 
during lactation could be modeled after strength training programs for postmenopausal 
women (35). 
Drinkwater and Chesnut (46) observed decreases in femoral neck and radial shaft 
BMD in six female athletes during pregnancy, but found an increase in tibial BMD.  
After 6 months of lactation in these same six subjects, radial shaft BMD returned to 
normal, while femoral neck BMD continued to decrease.  A non-significant decrease in 
lumbar spine BMD was also detected after 9 months of pregnancy and during lactation.  
This study compared these active pregnant and subsequently lactating women to a group 
of non-pregnant, non-lactating women.  Decreases in bone mineral density observed in 
the lactating women were not seen in the non-pregnant, non-lactating group.  There was 
no comparison of exercising lactating women to non-exercising lactating women in this 
study.  It is well established that BMD decreases during lactation, especially during the 
first few months.  Losses range from 3-5%, with some losses seen as high as 10%.  
Women in the above study were very active athletes prior to and during the first two 
trimesters of pregnancy, however many tapered down their exercise during the third 
trimester.  Intensity and duration of exercise during the lactation period was not reported 
(46).  The non-significant decrease in lumbar spine observed in these athletes suggests 
that exercise may slow bone loss during lactation in this area.  Although this study did 
not have a control group, other studies report a significant decline in the lumbar spine 
among sedentary, lactating women (4, 8).  Taken together, these two studies (45, 46) 
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provided preliminary data that were used to design a clinical trial utilizing a specific 
aerobic and strength training program in breastfeeding women. 
Effect of Dietary Intake on Bone Changes During Lactation 
During the last trimester of pregnancy, calcium is deposited in the fetal skeleton, 
at approximately 200-250 mg/day.  Absorption efficiency is increased during pregnancy, 
suggesting no need for increased calcium intake above normal female needs (7).  While 
up to 300 mg of calcium is lost daily to breast milk, maternal calcium intake does not 
appear to affect BMD during lactation (2).  Calcium absorption efficiency returns to that 
at pre-pregnancy; however, renal calcium retention is increased (47), and urinary calcium 
losses are decreased during lactation (48).  At 2 months postpartum, breast milk calcium 
appears to come mostly from spinal trabecular bone, in a study of women consuming 
recommended levels of calcium (approximately 1200 mg Ca/day) (7).  Laskey et al. (2) 
also examined bone density loss during lactation, finding that the greatest losses occurred 
in the spine and femoral neck.  Women in the second study also had an adequate calcium 
intake at approximately 1400 mg/day.  Neither of these two studies found any 
relationship between calcium intake, breast milk calcium, or any bone loss factors.  Both 
research groups suggest that maternal metabolic changes (increased renal calcium 
retention and decrease urinary calcium losses) contribute to meeting breast milk calcium 
needs.  However, these metabolic changes are often not sufficient to meet breast milk 
calcium needs, therefore calcium is resorbed from the bone.  Long-term observational 
calcium supplementation studies in postmenopausal women, a group at high risk for poor 
bone density, have shown little effect of calcium intake alone on reducing hip fractures 
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(49, 50).  Similarly, in lactating women, calcium supplementation did not improve BMD 
(48).  In addition, dietary calcium intake is not related to bone turnover markers in 
lactating women (11).  Recently, in women with habitually low calcium intakes (<500 
mg/d), increasing calcium intake improved calcium balance, which, in turn may lessen 
bone losses during lactation (51).  The improvement in calcium balance in women with 
low calcium intakes (51), and the lack of effect of calcium supplementation during 
lactation (48), provides further evidence that there may be a threshold above which 
increased calcium intake will have no effect on bone loss (52).  This threshold is likely 
800-1000 mg, which is the recommended intake in adults. 
Adequate vitamin D intake is necessary for effective calcium absorption.  With 
sufficient vitamin D intake, postmenopausal women had a lower risk for osteoporotic hip 
fractures (53).  While vitamin D supplementation is unnecessary for lactating women 
consuming dietary vitamin D and receiving adequate sun exposure (54), low vitamin D 
intakes may affect proper calcium absorption, thereby affecting bone mineral density.  In 
women who do not receive adequate sun exposure, which is more common due to 
damaging effects of the sun, supplementing with high doses (4000 IU/d) of vitamin D 
increased circulating 25-hydroxyvitamin D in the mother and her breast milk (55).  The 
effect of vitamin D intake on bone mineral density during lactation has not been 
thoroughly investigated.   
While calcium and vitamin D are both necessary for bone health, an adequate 
total energy intake is also important for the health of bones, especially in women.  Until 
recently, reproductive function was linked to body mass, especially fat mass.  It was 
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suspected that amenorrhea was partially the result of a low percent body fat.  However, 
recent research indicates that, in fact, energy deficit (whether from caloric restriction or 
energy expenditure) is the actual culprit inducing hormonal changes.  Maintaining 
reproduction function and bone health is the result of adequate energy availability and is 
not based on body fatness (56).  Interestingly, a decrease in energy availability (through 
caloric restriction and increased exercise) suppressed bone formation and increased bone 
resorption in young exercising women, with lower energy availability exhibiting greater 
negative effects on bone turnover (57).  Increased aerobic capacity and decreased body 
weight and BMI, but not decreased body fatness, in women, was associated with 
increased femoral neck BMD (58). 
Recently, high protein, especially dairy protein, diets have been investigated for 
their effects during weight loss and on bone health (59).  Bowen et al. (59) reported that 
overweight women on a weight loss diet containing either high mixed protein or high 
dairy protein had increased losses of bone resorption markers in the urine, with higher 
losses in the mixed protein group.  The mixed protein group, however, also had an 
increase in bone formation.  Researchers concluded that the dairy protein group had less 
overall bone turnover, which is considered beneficial for bone health. 
Numerous other nutrients may play a role in bone health.  Macdonald et al. (60) 
investigated the effects of a variety of nutrients on bone loss in pre- and postmenopausal 
women.  After adjustment for energy intake and other confounding factors, calcium was 
associated with less femoral neck (FN) BMD loss; conversely, increased polyunsaturated 
and monounsaturated fatty acids, retinol, and vitamin E were associated with increased 
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FN BMD loss.  There was a high correlation between retinol and vitamin E, and the poly- 
and monounsaturated fatty acids, which may indicate covariance, but cannot be 
overlooked in their effects of BMD loss (60).  A higher ratio of n-6 to n-3 fatty acids has 
also been shown to be associated with lower BMD in both men and women (61).  In 
premenopausal women there were also positive associations with vitamin C, magnesium 
and potassium, nutrients found in fruits and vegetables, on FN BMD.  Whether these 
associations are related to the nutrients themselves, or with some other factor in fruits and 
vegetables, is not known (60).  It was also reported that increased potassium intake (via 
increased fruit and vegetable intake), or decreased renal acid load may have positive 
effects on bone health (62). 
 The role of dietary intake on bone formation, loss, and total turnover is complex.  
Identifying the role of individual dietary factors, and how multiple dietary factors work 
together (e.g. the ratio of protein to calcium) to impact bone health has not been 
determined. 
Summary 
Breast milk is the best food for infants, and lactation is a normal process of the 
female body.  Breast milk formation induces the resorption of calcium and other minerals 
from the maternal skeleton, resulting in decreased bone mineral density during this 
period.  While most women regain these bone losses upon cessation of lactation, some 
women do not fully recover bone losses incurred during lactation.  Calcium intake does 
not appear to have an effect on bone mineral losses during lactation.  On the other hand, 
exercise, especially resistance-type, has been shown to improve bone mineral density in 
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postmenopausal women.  The effect of a resistance and aerobic exercise program has not 
been studied in lactating women, and was, therefore, the purpose of the following 
research study. 
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INTRODUCTION 
An estimated 44 million Americans either have or are at risk for osteoporosis, 
eighty percent of whom are women.  In 2002, $18 billion was spent nationally on direct 
costs to treat osteoporosis, and costs continue to rise (1).  Not only is this a considerable 
financial drain, but the quality of life for these individuals will continue to decline.  
Improving bone status earlier in life may reduce the likelihood of developing poor bone 
mass in later adulthood. 
Bone loss during lactation is normal, is necessary to provide calcium for breast 
milk production (2, 3), and can range from 3-9% (4).  These losses usually reverse upon 
weaning (5, 6); however, some lactating women do not experience full reversal of these 
losses after cessation of breastfeeding (7).  Susceptible women include those nursing 
multiple babies, adolescent mothers, and women in the later childbearing years who may 
not be able to regain lost bone mass before transitioning into menopause (4).   
Minimizing bone losses during lactation may improve bone density post-weaning 
and decrease the risk of osteoporosis later in life.  Resistance type exercise has been 
shown to improve bone mineral density (BMD) in young women (8).  The effects of 
exercise on BMD during lactation have only recently been investigated (9, 10); however, 
no randomized intervention studies investigating the effects of specific resistance and 
aerobic exercise on BMD during lactation have been reported.  Drinkwater and Chesnut 
observed a decrease in femoral neck BMD in six active women during lactation (9), 
whereas Little and Clapp saw decreases at the femoral neck and lumbar spine in lactating 
women who were either sedentary or were participating in self-selected recreational 
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exercise (10).  The researchers of the second study (10) suggested that the type of 
exercise and short duration of the study were both factors that may have contributed to 
the lack of difference in BMD changes between groups. 
Bone mineral density has been studied extensively in postmenopausal women, 
who experience similar hormonal changes (low estrogen levels) and bone loss as those 
that occur during lactation.  Exercise interventions to improve BMD in postmenopausal 
women have been shown to be effective (11); therefore, it can be rationalized that a 
similar intervention would be beneficial for the lactation period.  It is clearly established 
that exercise is safe during lactation and does not negatively impact breast milk volume 
and composition (12, 13). 
Lactation has been suggested as a possible contributing factor for postmenopausal 
osteoporosis in women whose bone density does not completely recover to pre-pregnancy 
levels upon weaning; however, results of studies are inconclusive (2).  In fact, recent 
epidemiological research suggests higher bone density in women who breastfed their 
infants (14), compared to women who did not breastfeed their infants.   
 Measurement of bone turnover markers, in addition to BMD measured by dual 
energy x-ray absorptiometry (DXA), will greatly improve the understanding of bone 
changes during lactation.  While correlations between BMD and bone turnover markers 
are not strong, each measurement provides important insight.  Bone turnover markers are 
representative of current physiological status of bone, whereas BMD via DXA represents 
the cumulative effects of many factors (15), (i.e. genetics, diet, and exercise). 
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While evidence is growing to support resistance exercise for increased bone 
during the postmenopausal period, there is a paucity of data available examining the role 
of moderate exercise on bone changes during lactation.  The aim of the present study was 
to determine the effects of a specific resistance and aerobic training program on BMD 
and bone turnover markers during lactation.  We also examined the role of dietary intake, 
specifically calcium, protein, and energy intake, on BMD and bone turnover during 
lactation.
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SUBJECTS AND METHODS 
Subjects 
Healthy (free from chronic disease and hormonal disturbances), non-smoking, 
sedentary (no exercise during the prior three months), exclusively breastfeeding (no more 
than 4 ounces of formula fed only occasionally) women, aged 23-37 yrs, with a body 
mass index of 20 to 30 (kg/m2) at 2 to 3 weeks postpartum were recruited through 
prenatal education classes offered at the Women’s Hospital of Greensboro and flyers 
(Appendix B) posted at local obstetricians’ offices.  Women were screened over the 
telephone and were excluded if birth was by a cesarean section.  Based on studies of bone 
loss during lactation (10, 16), power calculations estimate that a final sample size of 20 
(10 women per group) will provide significant power to detect a 10% difference in 
change in BMD between groups.  Written informed consent was obtained from all 
participants prior to admission into the study, and all women obtained medical clearance 
from their personal physician (Appendix B).  This research project was approved by the 
Institutional Review Board of the University of North Carolina at Greensboro.   
Measurements 
All measurements were taken at baseline (3 ± 2 wks; range 2.5 – 4.75) and 
endpoint (21 ± 2 wks; range 19 - 23), before a 16 week intervention. Participants came to 
the Human Performance Laboratory at the University of North Carolina at Greensboro 
for anthropometric, fitness and strength assessment, as well as for blood collection.  
Women traveled to Wake Forest University Baptist Medical Center, J. Paul Sticht Center 
on Aging (Winston-Salem, NC) for dual energy x-ray absorptiometry (DXA) 
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measurements.  Participants were met by a research assistant at the DXA facility to assist 
with childcare and to obtain DXA data from the participant. 
Upon completion of baseline measurements, participants were subsequently 
randomly assigned to an intervention or control group, stratified for parity.  Prior to the 
endpoint measurements, a urine sample was collected and tested to verify that the woman 
was not pregnant before she had the final bone density measurement. After birth, 
menstruation will not resume for at least 8 weeks in non-lactating women.  During 
lactation, menstrual cycles may not resume for 18 months (17); therefore, a pregnancy 
test was unnecessary at the baseline test.  Postpartum return of menses was documented 
in all women as return of menses has been shown in numerous studies to decrease bone 
losses during lactation (15, 18).  Menstrual cycles return at various times during the 
lactation period, and are highly individual.  Return of menses is not subject to alteration 
for research purposes, and therefore was documented and considered in the analysis. 
Anthropometrics and Body Composition 
Weight to the nearest 0.1 kg was measured on a stationary beam balance with 
subjects wearing only light clothing.  Height was measured without shoes by a 
stadiometer to the nearest 0.1 cm.   
BMD was measured using DXA (Hologic Delphi A, Delphi XP software version 
12.3; Hologic, Bedford, MA).  DXA measurement sites included whole body, lumbar 
spine (L1-L4), and hip (left, including femoral neck, trochanter and Wards triangle).  
Subjects were placed in a supine position while an x-ray beam scanned the entire body at 
1-cm intervals.  Changes in BMD, as well as bone mineral content (BMC) and bone area 
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(BA), are reported as percent change from baseline to endpoint, to account for individual 
variability.  Lean and fat mass were also measured by DXA. 
Bone turnover markers 
Serum and urine samples were collected at baseline and at endpoint for analysis 
of bone turnover markers.  Blood was collected by a trained phlebotomist in the morning 
after an overnight fast.  Urine (from first or second morning void) was collected, by the 
participants, in the morning on the day of their visit to the laboratory.  Serum (5 ml) was 
collected into an EDTA free vacutainer for analysis of bone-specific alkaline phosphatase 
(U/L; BAP), a bone formation marker.  Serum was frozen at -70˚C until analyzed by 
enzyme immunoassay (Metra BAP EIA kit, Quidel Corporation, San Diego, CA).  Urine 
(5ml) was collected for analysis of pyridinium crosslinks [deoxypyridinoline (DPD) and 
pyridinoline (PYD)], a bone resorption marker.  Urine was frozen at -70˚C until analyzed 
by enzyme immunoassay (Metra PYD EIA kit, Quidel Corporation, San Diego, CA).  
Pyridinium crosslinks were corrected for urine concentration by measurement of 
creatinine (mmol/L), which was measured by a standard colorimetric (alkaline picric 
acid) assay (Oxford Biomedical Research, Oxford, MI). 
Exercise Testing 
 
To assess the cardiovascular fitness level of the participants, a modified Balke 
protocol (19) submaximal graded treadmill test was used.  Subjects wore a heart rate 
monitor (Polar, Inc., Woodbury, NY) throughout the exercise bout, and resting heart rate 
(RHR) was measured immediately prior to exercise.  Submaximal heart rate was 
determined for each subject using the heart rate reserve formula [(220-age-RHR) x 85% 
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+ RHR] (19).  To avoid injury, subjects were asked to stretch before beginning the test, 
and the subjects warmed up on the treadmill for two minutes.  Treadmill speed was 
chosen by the participants, at what they felt was a challenging level.  This speed 
remained constant throughout the test.  Heart rate was measured and recorded every 
minute, as well as level of perceived exertion.  Treadmill grade was increased by 2.5% 
every two minutes.  Participants walked on the treadmill until their heart rate reached 
85% of their predicted maximal heart rate, unless discomfort or fatigue was expressed.  
Predicted oxygen consumption (VO2) was determined using the formulas of the 
American College of Sports Medicine (ACSM) (19) as follows: 
     VO2 (walking) = (3.5 ml/kg x min) + (speed in m/min x 0.1) + (grade x m/min x 1.8) 
     VO2 (running) = (3.5 ml/kg x min) + (speed in m/min x 0.2) + (grade x m/min x 0.9) 
Linear regression was used to determine the subject’s predicted VO2max using 
heart rate as the independent variable and predicted VO2 as the dependant variable. 
Muscular strength was measured by the 1 repetition maximum (RM) method as 
described by the ACSM (19), in the Human Performance Laboratory.  Subjects warmed-
up the muscles to be tested by lifting 40-60% of perceived maximum, 5-10 times.  After a 
1-minute rest, 5 more repetitions were performed at 60-80% of perceived maximum.  
After 3-5 minutes of rest, a small amount of weight was added until the weight could not 
be lifted.  The 1 RM was determined as the last weight successfully lifted.   
Dietary Analysis 
 
Dietary intake was determined by 24-hour recall over the telephone using the 
Minnesota Nutrition Data System for Research (NDS-R, Nutrition Coordinating Center, 
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University of Minnesota, MN) software, on two randomly selected days in the week prior 
to and during the last week of the intervention period.    Whenever possible, this included 
one weekday and one weekend day.  The software is designed to allow for immediate 
dietary input during the interview, and dietary analysis is subsequently generated.  A 
trained interviewer (MJB) used a five-pass method to collect detailed information about 
food consumed in the previous 24 hours.  Interviews were completed in approximately 
20-30 minutes.  Women were informed that they would be called in the week prior to and 
during the last week of the study period, but were not given the randomly selected day.  
Before the women were telephoned for their interview, they were given handouts of two-
dimensional visual food portions.  These tools aided the subjects in determining portion 
sizes of food they consumed.  This method has been used in the National Health and 
Nutrition Examination Surveys, and has been validated against both in-person 
administrated recalls (20) and observation (21).  All women were given a multivitamin 
(provided by the researchers, containing vitamin D) supplement; however, the 
supplement did not have any minerals (Appendix B), and was to be taken daily during the 
16-wk intervention period.  Many postpartum women are encouraged to take a 
multivitamin by health care professionals.  The provided vitamin contained folic acid, 
which is vitally important if the participants were to become pregnant during the study 
period.  Women were asked about multivitamin compliance every two weeks during the 
intervention.  All women in the study were instructed not to change their dietary intake or 
restrict their calorie intake during the 16-week intervention period. 
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Exercise Program 
In the intervention group, women participated in a 16-week home-based exercise 
program.  Women were provided with a heart rate monitor, an exercise ball and handheld 
weights to facilitate the exercise in the home.  All women (exercise and non-exercise) 
were given the exercise ball and weights as compensation for participation in the study.  
Research assistants traveled to participants’ homes 3 days per week to train mothers in 
the exercise program and to ensure exercise compliance (i.e. observation of exercise 
and/or checking the data saved on participant’s heart rate monitors) during the study. The 
intervention consisted of aerobic (3 days/week) and resistive exercise (3 days/week).  
Participants were sedentary at the onset of the exercise program and the progression of 
the aerobic and resistance exercise program was individualized.  The aerobic program 
consisted of 45-minute sessions at an intensity of 65 to 80 percent of the woman’s 
predicted maximum heart rate.  Women wore heart-rate monitors (Polar, Port 
Washington, NY) to confirm that they were exercising at the prescribed intensity.  
Duration of aerobic exercise began at 15 minutes per day, progressing to 45 minutes per 
day by increasing the time spent in their target heart-rate range by 5 minutes each day for 
the first week and by 3 minutes per day thereafter.  At the beginning of the intervention, 
when aerobic exercise duration was short, aerobic and resistance training was completed 
on the same day.  Once aerobic exercise duration increased to at least 30 minutes, 
subjects trained aerobically 3 days per week and did resistance training on alternating 
days, for a total of 6 days/week of training.  Each exercise session was preceded by a 5-
minute warm-up, and ended with a 5-minute cool-down period, to avoid injury.   
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The resistance program focused on structural exercises that involved direct force 
through the axial skeleton. Exercises included squats, deadlifts, high pulls, standing 
shoulder press, bent-over dumbbell row, isometric pushups, ball bench press, abdominal 
plank, crunches, and a wall sit.  Subjects completed 3-4 sets of each exercise using a 
weight that was equal to 60%, and progressed to 85-90%, of their initial 1 RM.  Subjects 
had 1-3 minutes of rest between sets.  All of these exercises were completed in the home 
with handheld weights and exercise balls provided by the researchers.   
 Women in the control group were instructed not to perform vigorous aerobic or 
resistance exercise more than once per week.  They were offered the exercise program 
and equipment after they had completed the baseline and endpoint measurements.  This 
incentive aided in subject recruitment and encouraged women to agree to random 
assignment to the research groups. 
Statistical analysis 
 Data were analyzed with JMP (v.5.1.2, SAS Institute, Cary, NC) statistical 
software.  Student’s t tests were used to determine differences in baseline subject 
characteristics.  Pearson’s correlations were conducted to determine any existing 
relationships between dietary intake, especially energy, calcium, and protein, and bone 
mineral density and bone turnover markers to determine factors for analysis of covariance 
(ANCOVA).  ANCOVA was used to determine actual differences between groups, using 
baseline measurements as the covariate, in BMD, BA, BMC, bone turnover markers, 
strength and predicted maximal oxygen consumption.  Differences between groups with 
respect to changes in BMD, BMC and BA were evaluated with ANCOVA, with the 
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differences between the endpoint and baseline measurements of BMD, BMC and BA as 
the outcome variables and parity, diet (energy, calcium and protein), and measurements 
of BMD, BMC and BA at the beginning of the study as the covariates.  ANCOVA was 
also performed to determine the effects of diet and exercise on the changes in bone 
turnover markers, controlling for baseline measurements.  In the ANCOVA models, 
covariates with p<0.10 were removed from the model.  
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RESULTS 
One hundred twenty four women were screened for this study, 26 were not 
eligible to participate.  Of the remaining 98 eligible women, 74 were no longer eligible 
after delivery due to the one of the following reasons:  change in health status (n=3), 
personal reasons (time constraints, work status, scheduling conflicts, n=30), delivery was 
cesarean section (n=21), or unwillingness to randomize to group (exercise vs. non-
exercise; n=20).  Twenty-four women were recruited and completed baseline 
measurements.  A final sample of 20 women (control n=10, exercise n=10) completed 
baseline and endpoint measurements.  Four women did not complete the study because 
they were no longer exclusively breastfeeding (there were no significant differences in 
their baseline characteristics as compared to the women who completed the study).  At 
baseline, characteristics of the participants were not significantly different between 
groups (Table 1).  Participants in this study were non-obese, aged 25-35, and were either 
Caucasian (n=19) or Asian (n=1).  Eight women [control group (CG) n=3, exercise group 
(EG) n=5] started hormonal birth control (progesterone-only pill or IUD), and two 
women (CG n=1, EG n=1) resumed menses during the study period.  All of the 
multiparous participants breastfed their previous children for at least 3 months. 
At baseline, no significant differences in cardiovascular fitness (Table 2) or 
muscular strength were observed between groups.  Both groups experienced a non-
significant increase in VO2 over the study period; however, there was no significant 
difference between groups.  The EG had increased muscular strength (actual and % 
change) after the intervention period in all areas tested (p<0.05), except for push-ups 
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(p=0.07) (Table 3).  Compliance for exercise was calculated as a percentage (number of 
sessions completed out of the total required over the 16 weeks) for both the aerobic 
training and the resistance training portions of the program.  Average aerobic compliance 
was 85%, and resistance compliance was 94% of the total requirement. 
Total body mass lost (kg) between groups was not significantly different.  There 
was a trend for the EG to have lost significantly less LBM than the CG (p=0.05).  Percent 
body fat decreased in both groups over the intervention period, with the EG losing a 
greater percentage body fat than the CG (p=0.09) (Table 4, Figure 1). 
Losses of lumbar spine (LS) BMC and BMD were significantly less in the EG as 
compared to the CG (p<0.05); however, no significant differences were detected between 
groups in whole body or hip BMC or BMD changes, and there were no differences in BA 
between groups in any body region (Table 5).  Multiparous women (n=10), who had all 
breastfed their previous children, lost significantly less whole body BMC and BA than 
the primiparous women (p<0.05), and there was a trend towards less loss of LS BMC 
(p=0.08) and LS BMD (p=0.08) (data not shown). 
There were no significant differences in dietary intake between groups at baseline 
or after the 16 wk intervention period (Table 6).  Because baseline and endpoint Ca 
intakes were highly correlated, calcium intake was averaged over the 4 days (including 
baseline and endpoint).  Because dietary intake did not differ between groups, all 
participants were grouped together (n=20) for analysis of the effects of dietary intake (4 
day average) on bone changes.  Calcium intake was correlated with vitamin D intake 
(R2=0.83, p<0.05) and the calcium to protein ratio (Ca:Pro) (R2=0.74, p<0.05).  In 
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addition, there was a weak association with Ca:Pro and protein intake (R2=0.11, p<0.05).  
Whole body BMD losses were minimized as calcium intake increased (R2=0.28, p<0.05), 
as protein intake increased (R2=0.15, p=0.09) and with an increase in the calcium to 
protein ratio (Ca:Pro) (R2=0.18, p=0.059).  Calcium and protein intake were not 
correlated with whole body BA, or LS and hip BMD, BMC, or BA (data not shown).  
After determining that there was a difference in BMC and BA between multiparous and 
primiparous women, a model (ANCOVA) was constructed that included calcium intake, 
group (exercise vs. non-exercise), and parity.  This model determined that calcium intake 
was a significant predictor of changes in whole body BMD, when parity was included in 
the model (R2=0.73, p<0.0001), but not group.  In the same manner, a model including 
Ca:Pro ratio and parity was a significant predictor of whole body BMD changes 
(R2=0.70, p<0.001).  There was no relationship between change in energy intake and 
BMD, BMC or BA in whole body, LS or hip. 
 Markers of bone turnover were analyzed in all participants; however, one 
participant in the exercise group was diagnosed with hypothyroidism at the end of the 
study period and her bone turnover markers were greater than two standard deviations 
higher than the rest of the participants, therefore her data were excluded.  Markers of 
bone formation (BAP) and bone resorption (pyridinium crosslinks) were not significantly 
different between groups at baseline or after the intervention period; however, the CG 
had an increase, while the EG experienced a decrease, in bone formation (from baseline 
and endpoint) (p<0.05) (Table 7).  A model (ANCOVA) that included calcium intake, 
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group and parity did not significantly account for the variability of markers of bone 
turnover. 
In addition, an ANCOVA model was constructed to determine the effects of 
parity, group (exercise vs. non-exercise), calcium intake, BAP, and pyridinium crosslinks 
on whole body, LS, and hip BMD, BMC, and BA.  Parity, change (decrease) in 
pyridinium crosslinks, and group accounted for 65% of the variability of LS BMC 
(R2=0.65, p<0.01), i.e. a higher parity, a decrease in bone resorption, and exercise 
predicted that there would be less loss of LS BMC.  Parity, change (increase) in BAP, 
and group accounted for 71% of the variability of LS BMD (R2=0.71, p<0.001), i.e. a 
higher parity, an increase in bone formation, and exercise predicted that there would be 
less loss of LS BMD.  Bone turnover markers were not significant predictors of whole 
body BMD, BMC or BA, or LS BA. 
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DISCUSSION 
The results of this study demonstrated that exercise minimized losses of LS BMD 
and LS BMC in breastfeeding women.  It has been observed that breastfeeding causes a 
loss of BMD in the spine and hip regions, but losses have been less pronounced in the 
whole body (17, 22).  Breastfeeding women undergoing a 16-week resistance and aerobic 
training program lost significantly less BMD and BMC (p<0.05) in the lumbar spine 
region, but not in the hip region or whole body. 
This is the first study, to our knowledge, to investigate the effects of a very 
specific exercise program on bone changes during lactation.  Few studies have examined 
the effects of exercise on BMD during lactation (9, 10), and to our knowledge there are 
no published studies investigating the effects of exercise on bone turnover markers during 
lactation.  Little and Clapp (10) detected no effect of exercise on inhibition of bone 
mineral loss in lactating women who participated in self-selected recreational exercise 
(walking, running, aerobics, step aerobics, stair machine).  These women were compared 
to non-exercising controls.  All subjects (both exercisers and non-exercisers) presented 
with femoral neck and lumbar spine BMC or BMD losses at 3 months postpartum.  The 
non-exercisers, however, had greater losses at the lumbar spine than the exercisers, but 
the difference was not significant.  It was suggested, by these authors, that a planned 
intervention, utilizing both resistance and aerobic exercise may provide the necessary 
stimulus to improve BMD during lactation (10).  Similarly, Drinkwater and Chesnut (9) 
observed decreases in femoral neck and radial shaft BMD in six female athletes during 
pregnancy, but found an increase in tibial BMD.  After 6 months of lactation in these 
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same six subjects, radial shaft BMD returned to normal, while femoral neck BMD 
continued to decrease.  A non-significant decrease in lumbar spine BMD was also 
detected after 9 months of pregnancy and during lactation.  Their study compared these 
active pregnant and subsequently lactating women to a group of non-pregnant, non-
lactating women.  Decreases in bone mineral density observed in the lactating women 
were not seen in the non-pregnant, non-lactating group.  There was no comparison of 
exercising lactating women to non-exercising lactating women in that study.  In contrast 
to these two studies (9, 10), our study utilized a specific resistance and aerobic training 
program to determine the effects of exercise on BMD and bone turnover during lactation.   
The exercise program developed for this study was 16 weeks in duration.  
Strength training programs, at a minimum, should be at least 8 weeks in duration to allow 
for neural adaptations (23), after which muscular hypertrophy will occur.  The first few 
weeks of our program were designed to familiarize the participants to the program, to 
decrease likelihood of injury.  By week 5, the aerobic portion of the program was at full 
intensity.  While a program lasting longer than 16 weeks may be more effective, it was 
not feasible for this study.  The bone turnover cycle is upregulated to 3-4 months during 
lactation (4); therefore, the 16 weeks of this intervention would allow for a full cycle of 
bone turnover to occur.  Introduction of solid foods to the infant normally begins around 
4-6 months, therefore, the first 5-6 months of exclusive breastfeeding was our focus, in 
that the greatest turnover of the mother’s bones will occur in this time frame.  Our 
program consisting of 3 days of aerobic exercise and 3 days of resistance training per 
week was effective in increasing strength in all areas assessed; however, there was no 
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difference between groups in the improvement in cardiovascular fitness.  This may be, in 
part, due to some lack of compliance (too great of a time commitment for mothers of 
small children), or that in order to see greater improvements in cardiovascular fitness, 
more than 3 days a week are necessary.  A research assistant was present in the home 3 
days per week, usually during the strength training sessions, which may also explain the 
lower compliance with the aerobic training.  Another possible explanation for the lack of 
difference between groups is that the non-exercising group also experienced 
improvements in cardiovascular fitness.  The study began at around 3 weeks postpartum, 
and all women participating in this study were still recovering from the birth process and 
would likely have fitness improvements between baseline and endpoint measurements. 
As hypothesized, the exercising women had substantial improvements in body 
composition.  Mean weight loss was not significantly different between groups; however, 
the decrease in % body fat was greater in the exercising women (p=0.09).  Exercising 
women were able to maintain most of their lean body mass, while the non-exercising 
group lost lean mass (p=0.05).  While it may have been expected that the exercising 
women would have gained lean body mass (i.e. muscle mass), this gain in muscle mass 
may have been masked by early postpartum fluid losses (i.e. at baseline, women may 
have appeared to have more lean body mass because they had not yet lost excess fluid 
retained from pregnancy).  Therefore, the net loss of lean body mass (-0.7 kg) 
experienced by the exercising group is likely an effect of fluid changes and a decrease in 
bone mineral density, and not a lack of increase in muscle mass.  Body water was not 
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measured in this study, and likely would have provided insight into lean body mass 
changes. 
Women in this study were stratified into groups by parity, and all but one of the 
multiparous women had two children.  Whole body BMC and BA losses were 
significantly less in our multiparous women (p<0.05), and a trend was noticed for 
multiparous women to have less loss of LS BMC and BMD.  The beneficial role of parity 
on bone during lactation may not necessarily be from simply having other children; 
rather, having breastfed previous children may be providing the beneficial effects (24). 
Caird et al. reported that femoral neck BMD was lower in multiparous women, as 
compared to nulliparous women (1.1 % BMD loss per live birth); however, they found a 
1.5% increase in LS BMD per breast-fed child (24). 
Postpartum amenorrhea, postpartum return of menses, and use of hormonal birth 
control have all been associated with changes in bone in breastfeeding women, yet results 
are inconclusive (5, 22, 25).  In the current study one women in each group experienced 
return of menses during the study period.  Eight women started hormonal birth control 
during the study; however, all were either taking oral progesterone-only mini pills, or 
were using an intrauterine device that did not involve systemic hormonal changes (i.e. 
hormones were retained in the uterus).  Bone changes in these women were not 
significantly different from the other participants.   
In breastfeeding women, approximately 300 mg of calcium is lost to breast milk 
each day; however, BMD during lactation has not been thought to be affected by 
maternal calcium intake (21).  Metabolic changes during pregnancy (increased calcium 
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absorption efficiency) and lactation (calcium absorption efficiency returns to pre-
pregnancy levels, increased renal calcium retention, and decreased urinary calcium 
losses) (26) are necessary to provide calcium for breast milk.  Calcium supplementation 
studies have shown that there is no positive effect of calcium supplementation on BMD 
or bone turnover markers during lactation in women with sufficient intakes (27), 
therefore it has been proposed that metabolic changes have a stronger effect on calcium 
regulation than dietary intake.  In addition, the role of protein on maintenance of bone 
mass has come under investigation.  It is proposed that protein (28), rather than energy 
intake may help to maintain bone mass.  Therefore, the ratio of calcium to protein may 
also be an indicator of a person’s ability to maintain bone mass.  In the current study, 
calcium intake and the calcium to protein ratio were both weak, yet significant, predictors 
of whole body BMD.  The strength of this prediction was improved when parity was a 
covariate.  Women with higher calcium intakes, and who were multiparous, lost 
significantly less whole body BMD.  The same effect was seen with the calcium to 
protein ratio. 
Caloric intake was not significantly different from baseline to endpoint within or 
between groups.  Interestingly, change in caloric intake from baseline to endpoint was 
greater in the non-exercising group [CG = -422(438), EG = -192(388) kcal], yet there 
was no difference in body mass lost [CG = -3.5(1.6), EG = -3.6(2.5)].  Exercising women 
were able to consume more calories, offset by increased exercise, while losing the same 
amount of total body mass, yet maintaining lean body mass.  In a recent study, a decrease 
in energy availability (through caloric restriction and increased exercise) suppressed bone 
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formation and increased bone resorption, with lower energy availability exhibiting 
greater negative effects on bone turnover (29).  While differences in caloric intake were 
not significant between groups in our study, there was a decrease in bone formation in the 
exercising group, possibly indicating a slowing of overall bone turnover. 
Bone resorption (pyridinium crosslinks) decreased in both groups over the study 
period.  Bone resorption is very high at the end of pregnancy and decreases postpartum in 
both breastfeeding and non-breastfeeding mothers (30, 31).  Measuring bone turnover 
markers at baseline and endpoint is sufficient in 6 month studies (32, 33); however, due 
to fluctuations in bone response, an effect of the training program may have occurred 
before our endpoint measurement.  Bone formation was not significantly different 
between groups at baseline or endpoint.  When parity (individual R2=0.11, NS), change 
in pyridinium crosslinks (individual R2=0.09, NS), and exercise grouping (individual 
R2=0.36, p<0.001) were modeled to predict changes in LS BMC, 65% of the variability 
of LS BMC was explained, corrected for baseline LS BMC (individual R2=0.13, NS).  
Having breastfed previously, participation in our exercise program, and experiencing a 
decrease in bone resorption are all factors that contribute to preserving LS BMC.  A 
similar model was created for LS BMD, and 71% of the variability of LS BMD, 
corrected for baseline LS BMD (individual R2=0.24, p<0.05), was explained by parity 
(individual R2=0.07, NS), group status (individual R2=0.3, p<0.05), and change in bone 
formation markers (individual R2=0.06, NS).  We did not observe a relationship between 
bone turnover markers and whole body or hip BMD or BMC.  Others have seen only 
moderate correlations (ranging from –0.29 to –0.48) between BMD and bone turnover 
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markers in postpartum women (15).  It is not surprising that our exercise program had no 
effect on whole body BMD, while having positive effects on LS BMD.  The lumbar spine 
(axial skeleton) is composed of the highly metabolic trabecular bone, which has a much 
higher turnover rate, as compared to the whole body, and is more susceptible to rapid 
gains and losses (10, 27). 
In conclusion, women who participated in our 16-week resistance and aerobic 
training program lost significantly less LS BMC and LS BMD than non-exercising 
controls.  The exercise program was also successful in improving body composition 
(decreased % body fat and maintenance of lean body mass).  In breastfeeding women 
who had adequate caloric intakes, calcium intake and the calcium to protein ratio were 
positively correlated with whole body BMD, especially in women who have breastfed 
other children.  Additional studies are needed to determine the effects of this exercise 
program upon weaning, in both the exercising and non-exercising women, and also in 
women who continue to exercise after participating in the program and those who do not.   
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TABLE 1 
Subject characteristics at baseline1, 2
 
Control Group (n=10)  Exercise Group (n=10) 
Age (y)   31.6 (2.8)        31.1 (3.0) 
Parity3    Primiparous=4  Primiparous=5 
    Multiparous=6  Multiparous=5 
Prepregnancy wt (kg)  60.6 (9.7)        62.7 (11.8) 
Baseline wt (kg)  68.7 (12.2)        68.7 (10.1) 
Height (in)   65.3 (3.1)        63.9 (2.2) 
BMI (kg/m2)   24.8 (2.9)        26.1 (3.3) 
 
1 Mean (SD) 
2 p >0.05 for all variables 
3 All multiparous mothers breastfed their previous infants for at least 3 months 
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TABLE 2   
Cardiovascular fitness at baseline and endpoint1, 2
 
 Control Group (n=10) Exercise Group (n=10) 
 Baseline Endpoint % change Baseline Endpoint % change 
Predicted VO2
(ml/kg/min) 
32.3 (4.8) 34.4 (4.2) 6.9 (5.5) 31.1 (3.7) 34.7 (4.7) 11.4 (6.5) 
Predicted VO2 
(L/min) 
2.21 (0.46) 2.24 (0.48) 1.17 (6.17) 2.13 (0.31) 2.24 (0.37) 5.15 (5.44) 
Test duration (min) 12 (3) 13 (3) 15 (11) 12 (3) 13 (2) 8 (19) 
Resting Heart Rate 68 (3) 72 (9) 6 (13) 
105 71 (10) 73 (13) 2 (11) 
85% predicted max 
HR 
172 (3) 172 (3) -- 171 (4) 171 (4) -- 
HR at end of test 172 (5) 176 (5) 3 (4) 175 (5) 177 (6) 1 (3) 
Test speed (mph) 2.9 (0.4) 2.9 (0.4) 0.4 (6.3) 2.9 (0.4) 3.1 (0.4) 9.5 (17.5) 
Highest grade (%) 12.3 (3.4) 14 (3.4) 16.4 (13.1) 12.5 (4.1) 13.3 (2.9) 11.1 (22.6) 
1 Mean (SD) 
2 p>0.05 for differences between groups for baseline, endpoint, and % change 
 
 
 
 
 
 
 
 
 
TABLE 3 Muscular strength at baseline and endpoint1
 
 Control Group (n=10) Exercise Group (n=10) 
 Baseline Endpoint % change Baseline Endpoint % change 
Squats (lbs) 66 (15) 74 (21) 12 (11) 59 (10) 85 (14) 46 (25) 2
Bench Press 
(lbs) 
43 (14) 44 (16) 1 (5) 37 (5) 59 (7) 2 63 (32) 2
Ab Plank 
(sec) 
69.2 (40.2) 60.4 (29.5) -2.7 (37.4) 61.2 (50.8) 115.7 (64.0) 2 203.3 (249.2) 2
Military Press 
(lbs) 
35 (9) 36 (8) 5 (16) 33 (5) 44 (7) 2 34 (20) 2
Deadlift (lbs) 66 (15) 71 (22) 7 (15) 
106 57 (10) 92 (11) 2 63 (13) 2
Push-ups (#) 11 (7) 14 (7) 66 (161) 10 (6) 26 (9) 2 221 (198) 3
High Pulls 
(lbs) 
42 (9) 44 (13) 4 (13) 40 (8) 62 (9) 2 58 (22) 2
Dumbell Row 
(lbs) 
44 (14) 45 (9) 8 (28) 38 (15) 66 (13) 2 89 (46) 2
Wall sit (sec) 36.1 (14.7) 37.9 (28.5) -5.7 (40.9) 26.7 (17.9) 56.6 (32.2) 161.0 (118.2) 2
Crunches (#) 61 (72) 63 (85) -2 (25) 128 (83) 251 (36) 106 (91) 
 
1 Mean (SD) 
2 Significantly different from control group, p<0.05. 
3 Trend towards significant difference from control group, p=0.07. 
 
 
 
 
 
 
 
TABLE 4  Body composition at baseline and endpoint1
 Control Group (n=10) Exercise Group (n=10) 
 Baseline Endpoint % change Baseline Endpoint % change 
Weight (kg) 68.7 (12.2) 65.2 (13.0) -5.4 (2.9) 68.7 (10.0) 65.1 (11.1) -5.5 (3.6) 
Fat Mass (FM)       
   kg 23.1 (6.9) 21.2 (7.4) -9.4 (7.5) 23.5 (7.2) 20.5 (8.4) -14.3 (9.6) 
   % FM 33.1 (5.0) 31.8 (5.8) -4.3 (5.8) 33.56 (6.2) 30.6 (7.6) -9.5 (7.1) 2
Lean Body Mass 
(LBM) 
      
   kg 45.6 (6.2) 44.0 (6.4) -3.6 (2.3) 
107
45.23 (4.9) 44.5 (5.0) -1.6 (2.3) 2
   % LBM 66.9 (5.0) 68.2 (5.8) 1.9 (2.3) 4.3 (3.5) 266.4 (6.2) 69.4 (7.6) 
 
1 Mean (SD) 
2 Trend towards significant difference from control group, P<0.10. 
 
 
 
 
 
 
 
 
 
 
TABLE 5 
Percent change in bone mineral density (BMD), bone mineral content (BMC), and bone area1
 
1 Mean (SD) 
   Area (cm
2 Significantly different from control group, p<0.05. 
 Control Group (n=10) Exercise Group (n=10) 
 Baseline Endpoint % change Baseline Endpoint % change 
Whole Body       
   BMD (g/cm2) 1.07 (0.09) 1.06 (0.09) -0.8 (0.8) 1.09 (0.08) 1.09 (0.07) -0.6 (1.2) 
   BMC (g) 2093 (269) 2064 (267) -1.4 (1.0) 2105 (285) 2076 (290) -1.4 (1.7) 
   Area (cm2) 1953 (161) 1943 (167) -0.6 (1.0) 1919 (146) 1904 (159) -0.8 (1.2) 
Lumbar Spine       
   BMD (g/cm2) 1.07 (0.1) 1.0 (0.1) -7.02 (1.9) 1.05 (0.1) 1.0 (0.1) -4.8 (1.0) 2
   BMC (g) 62.4 (10.9) 58 (10.3) -7.1 (2.2) 59 (11.1) 56.7 (10.8) -4.0 (1.9) 2
   Area (cm2) 58 (6.4) 58 (6.4) -0.04 (2.2) 55.9 (6.2) 56 (6.4) 0.9 (1.5) 
Total Hip       
   BMD (g/cm2) 0.95 (0.1) 0.93 (0.1) -2.2 (2.9) 
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0.96 (0.1) 0.93 (0.1) -2.8 (2.4) 
   BMC (g) 30.3 (5.6) 29.8 (4.5) -1.1 (6.1) 29.2 (4.1) 29 (3.7) -0.4 (6.0) 
   Area (cm2) 31.6 (3.0) 31.9 (2.4) 1.2 (4.2) 30.5 (3.0) 31.2 (2.1) 2.4 (5.1) 
Femoral Neck       
   BMD (g/cm2) 0.9 (0.1) 0.8 (0.1) -3.82 (6.0) 0.9 (0.1) 0.8 (0.1) -4.2 (3.5) 
   BMC (g) 4.0 (0.6) 3.8 (0.5) -5.3 (5.7) 4.1 (0.6) 3.9 (0.6) -4.8 (6.5) 
   Area (cm2) 4.7 (0.4) 4.6 (0.5) -1.5 (5.7) 4.8 (0.4) 4.7 (0.5) -0.6 (5.2) 
Trochanter       
   BMD (g/cm2) 0.7 (0.1) 0.7 (0.1) -2.1 (2.8) 0.7 (0.1) 0.7 (0.1) -1.0 (3.3) 
   BMC (g) 6.4 (1.4) 6.4 (1.3) -0.3 (5.3) 6.42 (1.6) 6.5 (1.4) 1.8 (9.4) 
   Area (cm2) 9.41 (1.13) 9.6 (1.2) 2.0 (5.4) 9.26 (1.3) 9.5 (1.2) 2.7 (6.3) 
Ward’s Triangle       
   BMD (g/cm2) 0.8 (0.1) 0.8 (0.1) -1.7 (8.1) 0.9 (0.1) 0.8 (0.1) -7.1 (5.6) 
   BMC (g) 0.9 (0.2) 0.9 (0.1) 4.4 (19.3) 1.0 (0.1) 1.0 (0.1) -1.6 (6.2) 
2) 1.2 (0.1) 1.2 (0.1) 5.6 (13.7) 1.2 (0.1) 1.3 (0.1) 6.4 (10.7) 
 
 
 
 
TABLE 6 
Dietary intake at baseline and endpoint1, 2
    
Control Group (n=10)  Exercise Group (n=10) 
Kcal 
   Baseline   2112 (510)   2109 (556) 
   Endpoint   1690 (375)    1918 (388) 
Kcal change   -422 (438)   -192 (388) 
Fat (g) 
   Baseline   82 (21)    79 (26) 
   Endpoint   69 (17)    72 (21) 
Protein (g) 
   Baseline   74 (16)    87 (20) 
   Endpoint   79 (13)    75 (23) 
Vitamin D (mcg)3
   Baseline   4.3 (2.1)   6.3 (3.1) 
   Endpoint   4.5 (1.4)   6.4 (3.9) 
Calcium (mg) 
   Baseline   1125 (380)     1360 (555) 
   Endpoint   949 (352)   1207 (563) 
   Average4   1037 (279)   1284 (504) 
Ca:Protein 
   Baseline   15.2 (3.5)   15.8 (6.1) 
   Endpoint   12.2 (4.5)   15.5 (5.3) 
   Average4   13.4 (2.5)   15.6 (5.1) 
 
1 Mean (SD) 
2 p > 0.05 
3 Supplemental vitamin D not included 
4 Average of 4 days (2 baseline, 2 endpoint) 
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TABLE 7 
Markers of bone turnover1
 
Control Group (n=10)  Exercise Group (n=9) 
BAP2     
   baseline   25.1 (8.6)   31.0 (6.3) 
   endpoint   28.3 (9.7)        30.0 (6.1) 
   change   3.2 (4.7)   -1.1 (3.4)4
Pyridinium crosslinks3
   baseline   88.8 (39.7)   80.4 (36.2) 
   endpoint   42.0 (17.2)        31.1 (11.1) 
   change   -46.7 (28.2)   -49.3 (38.4) 
 
1 Mean (SD) 
2 Bone-specific Alkaline Phosphatase, U/L 
3 nmol/mmol creatinine 
4 Significantly different from control group, p<0.05. 
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FIGURE 1.  Mean (SD).  Difference in lean and fat mass loss from baseline to endpoint.  
There was no difference in total body mass lost between groups; however, the EG lost 
more fat mass, while preserving lean mass during the intervention period (* p=0.0549), 
compared to the CG. 
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EPILOGUE 
 
The research presented in this dissertation suggests that maternal exercise 
provides many benefits to mothers during lactation.  There is no negative effect of 
exercise on breast milk fatty acid concentrations, and there may actually be a positive 
effect.  A strength and aerobic training program minimized lumbar spine bone density 
losses in breastfeeding women.   
The two research studies presented in this dissertation were a collaborative effort 
of many individuals, including both the research teams and the women who volunteered 
to participate in the studies.  Recruitment for the bone study took much longer than 
expected, due to many reasons.  Rate of cesarean section deliveries was extremely high, 
and these women had to be excluded from the study, therefore prolonging recruitment.  In 
addition, we had many women who were unwilling to randomize to group, which is 
understandable for this population. 
The exercise program designed for this study was effective not only in 
minimizing bone losses, but also for improving body composition in these women.  On a 
more personal level, seeing first hand the changes in these women as they progressed 
through the program week by week was wonderful.  Body image improved tremendously 
in the women who were in our exercise group, and all were so thankful of the personal 
attention that they received throughout the study period. 
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Compliance was acceptable, considering the population studied.  These were free-
living mothers of newborns, some first time mothers, and most of the rest were mothers 
of young toddlers.  Exercising six times a week is a challenge; one has to be 
understanding of sleep deprivation, child and parent illness, and time management 
(especially in those participants who returned to work outside the home). 
If this study were to be repeated, I would definitely consider changing the dietary 
intake protocol.  The NDS-R program is excellent; however, asking postpartum women 
to complete 24-hour recalls was more of a challenge than was expected.  Pregnancy and 
lactation are a time marked by forgetfulness and fatigue.  Asking a mother what she ate 
24 hours before was harder than most would understand.  For many of the recalls, the 
participants asked if they could just write it down and call back, because that was easier 
and less stressful.  In the future I would use the 3-day weighed food records (as used in 
the fatty acid study), and then enter that information into the NDS-R program.  With the 
3-day record, the mothers can tape record their intake and/or write it down at their 
convenience, thereby reducing subject burden. 
A study following these women after weaning their infants is currently in 
progress.  This study should provide interesting data on bone recovery in the post-
weaning period.  Some of the women in the exercise group have continued to exercise 
while others have not, and some of the women in the non-exercising group have started to 
exercise.  Comparing the bone densities of all of these women will be very interesting.  
One could also consider studies that would vary the exercise program to determine 
exactly what components are effective (i.e. aerobic only, resistance only, other 
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combinations of the two types of exercise, higher intensity vs. lower intensity, any 
threshold levels above or below which exercise is more or less effective in minimizing 
bone loss).  If time and funding were available, conducting midpoint measurements of 
bone density and bone turnover markers would also give insight into the changes over the 
study period. 
Overall, this study was designed to find positive effects of exercise on bone 
density in breastfeeding women.  These results can be built on further research.  Our 
study was very specific with its methods and inclusion criteria for participants.  This may 
have lengthened recruitment time, but made the study much more relevant, and the 
findings more significant.  I was involved in every component of this study; including 
conception, design, recruitment, implementation, applied and basic laboratory 
assessment, data analysis, and even participation.  I look forward to seeing this study 
potentially replicated on a larger scale and the follow up weaning study results.  My time 
working on these studies, while lengthy, was enjoyable.
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APPENDIX A:  CHAPTER 1 PROTOCOLS
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PLASMA FATTY ACID PROFILE ANALYSIS 
(Du, January 1994) 
 
Principle 
 
This method used is an adaptation of Bligh and Dyer’s (1959) 
 
Materials 
  Test tubes: 125 x 16mm 
  120 x 10mm 
  100 x 10mm 
  Pipetman pipettes: 100µl 
   1000µl 
  Pasteur pipettes 
  N2 evaporator 
  Water aspirator 
  Repipettors 
  Test tube shaker 
  Vortex mixer 
  Centrifuge 
  Heat block 
  5ml volumetric flask 
 
Reagents 
  Internal standard: 17:0 methyl ester at approximately 10 mg/ml in iso-octane 
  HPLC grade: hexane, methanol, chloroform, and iso-octane 
  BHT (Butylated hydroxytoluene) 
  Sodium sulphate 
  Boron trifluoride in methanol 
  Benzene 
 
Procedures 
1.  Preparation of reagents 
Mix one part chloroform with two parts methanol, add 50 mg BHT in each liter of the 
mixture.  Place the mixture in a repipettor calibrated for 3.75 ml delivery.  Chloroform 
and distilled water are placed in another 2 repipettors calibrated for 2.5 ml delivery. 
2.  Extraction 
Put 15µl (5µl for LDL) 17:0 internal standard in a 100 X 10mm test tube with teflon cap.  
Blow dry on N2 evaporator. 
Add 0.2ml plasma in the test tube, add 0.8 0.9% saline for making a volume of 1ml. 
Add 3.75ml of 2:1 methanol and chloroform mixture in test tube and shake for 1 hour on 
the shaker. 
After shaking, centrifuge at 2000 rpm for 10 minutes.  Transfer the supernatant into a 120 
x 10mm test tube (with teflon cap) by pasteur pipette. 
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Extract the residue with 1ml distilled water and 3.75ml methanol-chloroform mixture.  
Vortex.  Centrifuge again for 10 minutes.  Transfer the supernatant to the same 120 x 
10mm test tube as in the first extraction. 
Add 2.5ml distilled water and 2.5ml chloroform in the 120 x 10mm test tube.  Mix.  
Centrifuge again for 10 minutes. 
Suck the upper portion out by using the water aspirator.  Withdraw the lower chloroform 
layer by pasteur pipette to another 100 x 10mm test tube.  Dry under nitrogen. 
3.  Methylation 
Add 0.2ml benzene and 1ml boron trifluoride-methanol in the nitrogen dried test tube.  
Cap tightly.  Place tube in 95ºC heat block for 90 minutes. 
Remove test tube from the heat block and cool to room temperature.  Add 5ml distilled 
water and 5ml hexane to the tube and mix for 2 minutes on vortex mixer. 
Centifuge tube at 1500 rpm for 10 minutes.  Transfer the top hexane layer with pasteur 
pipette to 125 x 16mm test tube. 
Add 2ml hexane to the first tube and mix again for 2 minutes on vortex mixer. 
Centrifuge at 1500 rpm for 10 minutes.  Remove hexane layer and combine it with first 
hexane portion. 
Add about 0.3g Na2SO4 to the combined extracts and mix for 45 seconds on vortex 
mixer. 
Transfer the extract to a 100 x 10mm test tube and evaporate hexane under nitrogen until 
dry. 
Reconstitute sample in 0.3ml iso-octane for plasma. 
Inject 1µl in GC. 
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Modified Folch Extraction of Total Lipids in Human Milk (Bitman et al.) 
 
 
Materials 
 
Test tubes: 50 ml 
  120 x 10mm 
  100 x 10mm 
Pipetman pipettes: 100µl 
   1000µl 
Pasteur pipettes 
N2 evaporator 
Vortex mixer 
Centrifuge 
Heat block 
Homogenizer  
 
Reagents 
 
Internal standard: 17:0 methyl ester at approximately 10 mg/ml in iso-octane 
HPLC grade: hexane, methanol, chloroform, and iso-octane 
BHT (Butylated hydroxytoluene) 
Sodium sulfate 
Boron trifluoride in methanol 
Benzene 
Sodium Chloride 
 
Extraction 
 
1. Add 150 μl of 10 mg/ml 17:0.  Dry under nitrogen. 
2. After heating to 80C for 1 minute to inactivate lipases, 1.0 ml of milk is placed in 
a 50 ml glass test tube with Teflon-lined screw cap containing 18 ml 
chloroform:methanol (2:1 containing 0.01% butylated hydroxytoluene).  
Dichloromethane can be substituted for chloroform.  Heating can be omitted if a 
fresh, or frozen and thawed, sample is extracted immediately.  If the sample has 
been lipolyzed, it should be acidified to pH 2.0 before extraction in order to free 
fatty acid soaps. 
3. Homogenize for 30 seconds using a Polytron homogenizer (KINEMATICA 
GmbH, KRIENS-LUZERN, Switzerland). 
4. Add 6 ml of 0.7% NaCl and invert tube a few times. 
 
5. Centrifuge at 1000rpm (260 x g) for 10 minutes. 
6. Remove upper (methanol/water) phase by suction pipette and discard. 
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7. Weigh large tube before aliquoting. 
8. Transfer and 8.0 ml aliquot of the lower chloroform phase to a tared (0.0000 
place) 15 ml culture tube. 
9. Transfer a 3.0 ml aliquot of the chloroform phase to a 4.0 ml amber vial.  The 
lipid in this vial will be used for thin-layer chromatographic separation and gas 
liquid chromatographic analysis of fatty acid methyl esters. 
10. Evaporate solvent under nitrogen (tube from step 6) and re-weigh. 
11. Determine % fat: ((tube + fat) – tube)) x 150 = % fat 
Methylation 
Dry 3.0 ml aliquot under nitrogen.  (tube from Step 9) 
Add 0.2ml benzene and 1ml boron trifluoride-methanol in the nitrogen dried test tube.  
Cap tightly.  Place tube in 95ºC heat block for 90 minutes. 
Remove test tube from the heat block and cool to room temperature.  Add 5ml distilled 
water and 5ml hexane to the tube and mix for 2 minutes on vortex mixer. 
Centifuge tube at 1500 rpm for 10 minutes.  Transfer the top hexane layer with pasteur 
pipette to 125 x 16mm test tube. 
Add 2ml hexane to the first tube and mix again for 2 minutes on vortex mixer. 
Centrifuge at 1500 rpm for 10 minutes.  Remove hexane layer and combine it with first 
hexane portion. 
Add about 0.3g Na2SO4 to the combined extracts and mix for 45 seconds on vortex 
mixer. 
Transfer the extract to a 100 x 10mm test tube and evaporate hexane under nitrogen until 
dry. 
Reconstitute sample in 0.3ml iso-octane for plasma.  Vortex.  Transfer 50 μl to small GC 
vial.  Add 450 μl iso-octane to vial. 
Inject 1µl in GC. 
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APPENDIX B:  CHAPTER 2 FORMS
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* ARE YOU EXPECTING OR DO YOU HAVE A NEW BABY?? 
 
* ARE YOU INTERESTED IN PARTICIPATING IN AN 
EXERCISE PROGRAM AFTER YOU HAVE YOUR BABY?? 
 
* DO YOU WANT TO GET IN SHAPE BY IMPROVING YOUR 
FITNESS LEVEL AND MUSCULAR STRENGTH?? 
 
* DO YOU PLAN TO EXCLUSIVELY BREASTFEED FOR THE 
FIRST 5 MONTHS POSTPARTUM?? 
YES? 
Then GIVE US A CALL! 
(You must be pregnant or your baby must be less than 2 weeks old) 
 
 
 
 
 
 
 
 
 
 
 
Be-Hip Mom! 
Research Study 
Lactation and Bone Mineral Density 
UNCG Departments of Nutrition and Exercise Science 
CALL: Dr. Cheryl Lovelady or Melanie Bopp at 336-256-1090 
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UNIVERSITY OF NORTH CAROLINA AT GREENSBORO 
 
Consent to Act as a Human Subject
 
PARTICIPANT’S NAME            
 
DATE OF CONSENT            
 
PROJECT TITLE:  Effect of Exercise Training During Lactation on Mother’s Bone 
Status 
 
INVESTIGATORS:  Cheryl Lovelady Ph.D., R.D., Laurie Wideman Ph.D.,  
Melanie Bopp, and Heather Kennedy 
 
DESCRIPTION AND EXPLANATION OF PROCEDURES:  The purpose of this study 
is to determine the bone status of the lactating mother as a result of resistance and aerobic 
exercise training.  The study will begin two to three weeks after you deliver and will 
continue until you are at your twentieth week postpartum.  If you consent to participate, 
you will be assigned by chance to one of two groups.  The first group will participate in 
the measurements and the exercise program.  If you are assigned to the other, or control 
group, you will participate in all the measurements described below but will not 
participate in the exercise program.  After completion of the project, the control group 
will be offered the opportunity to learn the procedures used in the experimental group to 
promote increased bone status through a personalized exercise prescription.  
 
Participants in both groups will be asked to do the following: 
1. Receive medical clearance from your physician, through the form provided, to 
participate in the exercise program. 
2. Participate in three short dietary recall sessions.  You will be called three times in 
one week at your convenience at the beginning and end of the study.  This diet 
record will be used to determine your nutritional intake.   
3. At 2 to 3 weeks and at 20 weeks postpartum you will be given a body scan by 
dual energy x-ray absorptiometry (DXA).  This whole-body scan is necessary to 
determine your bone density. The scan will be completed at the J. Paul Sticht 
Center on Aging at the Wake Forest University Medical Center in Winston 
Salem.  You will lay still and flat on an x-ray table, and the scanner will move 
back and forth several feet above you. The entire procedure takes approximately 
30-45 minutes, depending on your height. Your breast milk will not be affected 
by the DXA scan. 
4. At 20 weeks postpartum, you will be given a pregnancy test to ensure that you are 
not pregnant when the DXA scan is administered. 
5. Visit the Human Performance laboratory at UNCG for several measurements at 
the beginning (4 weeks) and end (20 weeks) of the study.  This visit should take 
less than 2 hours. 
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a) Your height and weight will be recorded first.   
b) Then your cardiovascular fitness will be determined through an exercise 
test on a treadmill.  You will walk or run on the treadmill, beginning at a 
low level, and will increase until you reach 85% of your calculated 
maximum heart rate.  A researcher certified in cardiopulmonary 
resuscitation (CPR) will be present at the exercise session.  Heart rate and 
rating of perceived exertion will be measured throughout this test.  
c) You will be asked to provide approximately 4 tbls of venous blood after 
an overnight fast (no alcohol for 24 hours prior to blood draw).  The blood 
will be drawn in the morning at the lab.  Venipuncture will be performed 
by a trained phlebotomist.  The blood is needed to assess your bone status. 
6. Muscular strength will be assessed at the beginning and end of the study.  We will 
be testing the strength of your muscles using hand weights.  
7. You will be asked to collect a small urine sample in the morning on the day of 
your visit to the lab.  The first void of the morning is preferable.  You will collect 
the urine sample into a sterile urine collection cup, and will need to store the 
sample in your home refrigerator until you come into the lab.  You will bring the 
sample with you to the lab. 
8. During the morning feeding on the day you visit the lab, you will collect 
approximately 4 tablespoons of breast milk.  While the infant is nursing on one 
breast, the milk sample will be obtained from your other breast (a breast pump 
will be provided if needed).  All samples must be chilled immediately in 
household refrigerator.  You will bring the sample with you to the lab. 
9. After 20 weeks of the study, you will be asked to repeat all of the measurements 
above.  
 
Those assigned by chance to the exercise group will also be asked to do the following: 
1. Participate in resistance exercise sessions (30-45 minutes) three times each week at 
your home.  All necessary equipment will be provided.  A video will be provided for 
instruction on proper weight training technique. You will also participate in aerobic 
exercise sessions (45 minutes) three times a week.  A qualified research assistant certified 
in CPR and educated on proper resistance training technique will be present at exercise 
sessions at least 3 times a week to monitor your training technique (to prevent injury), 
exercise intensity level, and heart rate. 
2. Participate in strength tests every six weeks to determine any necessary changes to 
your personalized resistance-training program. 
RISKS AND DISCOMFORTS:  The risk of injury during exercise exists for you; 
temporary muscle fatigue and/or respiratory discomfort may result from the graded 
exercise test.  Exercise sessions may result in temporary muscle soreness.  Insertion of 
the needle during venipuncture may be slightly painful.  Every precaution will be taken to 
minimize the risks involved with venipuncture (air emboli, infection, bruising, and 
fainting).  You will be exposed to very mild radiation from the DXA scan, equivalent to 
1/10 the exposure from a routine chest x-ray, and less than the exposure of a dental x-ray. 
There is no risk to your breast milk. 
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POTENTIAL BENEFITS:  Results of all the tests conducted will be provided to you at 
no cost.  Mothers participating in the study will undergo two free bone density scans, 
which provide valuable bone density and body composition information.  All participants 
will receive, at no cost, a stability ball, hand weights, and video for home exercise; 
however, women in the control group will not receive these materials until completion of 
the study.  Benefits to the exercising mothers also include the potential for increased 
cardiovascular fitness, increased muscular strength, and increased lean muscle tissue.  
 
COMPENSATION/TREATMENT FOR INJURY:  In the case of injury, you will be 
referred to your personal physician for treatment.  You are responsible for paying for 
your treatment for injury.  Upon completion of the study, you will receive a $50 stipend. 
 
CONSENT:  Your signature on this consent form indicates that you have read the 
procedures, risks and benefits involved in this research.  You are free to refuse to 
participate or to withdraw your consent to participate in this research at any time without 
penalty or prejudice; your participation is entirely voluntary.  Your privacy will be 
protected because you will not be identified by name as a participant in this project.  All 
collected data will be stored in a locked file cabinet and will be shredded when it is no 
longer needed. 
 
The research and this consent form have been approved by the University of North 
Carolina at Greensboro Institutional Review Board that ensures that research involving 
humans follows federal regulations.  Questions regarding your rights as a participant in 
this project can be answered by calling Eric Allen at (336) 334-5878.  Questions 
regarding the research itself can be answered by Dr. Cheryl Lovelady by calling (336) 
256-0310.  Any new information that develops during the project will be provided to you 
if the information might affect your willingness to continue participation in the project.   
 
By signing this form, you are agreeing to participate in the project described to you by 
________ 
             
Subject’s Signature      Witness to Signature 
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MEDICAL CLEARANCE FORM  APPLICANT’S SIDE 
 
This form is required for acceptance in the lactation study and must be completed by you and 
your attending physician.  This information along with your physician’s statement will be used 
for your participation in a graded exercise test and for prescription of an exercise program.  
Please check any of the conditions that apply to you.   
Name (Print)             
Age       Weight       Height      
 
1.  Do you have any of the following risk factors for heart disease? 
 Inactive lifestyle       High Blood Triglycerides   
 Stressful lifestyle     High Blood Cholesterol   
 Stroke       High Blood Pressure    
 Diabetes Mellitus       Obesity     
 Smoke Cigarettes (if yes, # per day         ) 
 Heart disease in family (if yes, please specify        
 
2.  Have you ever experience any of the following? 
 Chest pain  Discomfort/pain in the:  __throat     wrist  
 Chest Pressure      elbow     teeth 
 Palpitations/skipped heart beats       jaw 
  
3.  Do you have or has a physician diagnosed you as having any of the following? 
 Heart murmur  Chronic Bronchitis  Muscle/Bone/Joint problems 
 Emphysema  Arthritis   Neurological problems 
 Asthma  Allergies   Other (explain)     
 
4.  Have you ever undergone surgery for any of the following? 
 Varicose veins   Leg surgery   Abdominal Surgery 
 Hernia repair   Musculoskeletal  Other (explain)    
 
5.  Have you ever had any of the following tests? 
 Exercise Stress test  Coronary Angiography Echocardiogram 
 Holter Monitor  Exercise Stress test with Isotope 
  
6.  Please list all medications/supplements that you are taking. 
 Name of medication   Dosage  Doses/Day 
            
7.  Are you taking any diet pills or ephedra for weight loss?   YES  NO 
8.  Did you exercise vigorously before pregnancy?(circle one)  YES NO 
9.  Did you exercise regularly during your third trimester?(circle one) YES NO   
 
           
 Applicant’s Signature     Date  
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MEDICAL CLEARANCE FORM  PHYSICIAN’S SIDE 
 
 Please check and/or comment on additional history and all pertinent physical findings.  
This information will be used for the applicant’s participation in a graded exercise test and 
exercise program.   
 
Name of Applicant (print)         
Name of Physician (print)         
Physician’s Telephone  (           )       
Physician’s Address          
 
1.  Additional history not mentioned on APPLICANT’S SIDE: 
            
  
             
            
  
 
2.  Significant abnormal findings: 
HEENT      Pulses       
Chest               Extremities       
Heart               Neurologic       
Abdomen        Orthopedic      
Other                
Comments:              
             
  
3.  Please provide the following, if available: 
Total cholesterol      Blood pressure   /  
Triglycerides       Resting pulse       
LDL              HDL   
 
4.  I have examined the above-named individual and find no reason why she should not 
participate in a graded exercise test or other physical activities. 
            
   Physician’s Signature    Date 
 
PARTICIPANTS:  PLEASE BRING THIS FORM DIRECTLY TO CHERYL 
LOVELADY OR MELANIE BOPP.  PLEASE DO NOT HAVE YOUR PHYSICIAN’S 
OFFICE MAIL IT TO US.  THANKS. 
 
For further information, please contact: 
 Cheryl Lovelady, Ph.D., R.D. 
 UNCG Department of Food and Nutrition 
 Phone: (336) 256-0310 
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Multivitamin given to all participants: 
 
Vitamin A  5000 IU 
Vitamin C  60 mg 
Vitamin D  400 IU 
Vitamin E  30 IU 
Thiamin  1.5 mg 
Riboflavin  1.7 mg 
Niacin   20 mg 
Vitamin B6  2 mg 
Folic Acid  400 mcg 
Vitamin B12  6 mcg 
Pantothenic Acid 10mg 
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Resistance training Week 1 - Familiarization 
3 days per week – 60% - 1 set per exercise  **Please record date and weight lifted each day 
3 second lift – hold for 0 seconds – lower for 3 seconds          45-60 second rest between exercises          
Day 1  Squats Bench Press Military Press Sit ups  
Date: Number of Sets 1 1 1 1  
 Number of Reps      
 Pounds lifted:      
  Stiff leg deadlift Push up High Pulls Dumbbell row Ab plank 
 Number of Sets 1 1 1 1 1 
 Number of Reps      
 Pounds lifted:      
Day 2  Squats Bench Press Military Press Sit ups  
Date: Number of Sets 1 1 1 1  
 Number of Reps      
 Pounds lifted:      
  Stiff leg deadlift Push up High Pulls Dumbbell row Ab plank 
 Number of Sets 1 1 1 1 1 
 Number of Reps      
 Pounds lifted:      
Day 3  Squats Bench Press Military Press Sit ups  
Date: Number of Sets 1 1 1 1  
 Number of Reps      
 Pounds lifted:      
  Stiff leg deadlift Push up High Pulls Dumbbell row Ab plank 
 Number of Sets 1 1 1 1 1 
 Number of Reps      
 Pounds lifted:      
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Resistance training Weeks 2-6 
Alternate days – 70% - 10-15 reps per set      3 sets per exercise 
3 second lift – hold for 0 seconds – lower for 3 seconds                   **Please record date, weight lifted and number of reps each day 
45-60 second rest between exercises, straight or supersets 
 
 
WEEK 2       
Day 1  Squats Bench Press Military Press Sit ups  
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
Day 2  Stiff leg deadlift Push up High Pulls Dumbbell row Ab plank 
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
Day 3  Squats Bench Press Military Press Sit ups  
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
WEEK 3       
Day 1  Stiff leg deadlift Push up High Pulls Dumbbell row Ab plank 
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
Day 2  Squats Bench Press Military Press Sit ups  
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
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Day 3  Stiff leg deadlift Push up High Pulls Dumbbell row Ab plank 
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
WEEK 4       
Day 1  Squats Bench Press Military Press Sit ups  
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
Day 2  Stiff leg deadlift Push up High Pulls Dumbbell row Ab plank 
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
Day 3  Squats Bench Press Military Press Sit ups  
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
WEEK 5       
Day 1  Stiff leg deadlift Push up High Pulls Dumbbell row Ab plank 
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
Day 2  Squats Bench Press Military Press Sit ups  
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
Day 3  Stiff leg deadlift Push up High Pulls Dumbbell row Ab plank 
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Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
       
WEEK 6       
Day 1  Squats Bench Press Military Press Sit ups  
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
Day 2  Stiff leg deadlift Push up High Pulls Dumbbell row Ab plank 
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
Day 3  Squats Bench Press Military Press Sit ups  
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:     
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Resistance training Weeks 7-11 
Alternate days – 85% - 5-8 reps per set      4-5 sets per exercise 
2 second lift – hold for 0 seconds – lower for 2 seconds         **Please record date, weight lifted and number of reps each day 
2 minute rest between exercises, supersets 
 
WEEK 7       
Day 1  Stiff leg deadlift Push up High Pulls Dumbbell row Ab plank 
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
       
Day 2  Squats Bench Press Military Press Sit ups  
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
       
Day 3  Stiff leg deadlift Push up High Pulls Dumbbell row Ab plank 
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
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WEEK 8       
Day 1  Squats Bench Press Military Press Sit ups  
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
Day 2  Stiff leg deadlift Push up High Pulls Dumbbell row Ab plank 
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
Day 3  Squats Bench Press Military Press Sit ups  
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
WEEK 9       
Day 1  Stiff leg deadlift Push up High Pulls Dumbbell row Ab plank 
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
Day 2  Squats Bench Press Military Press Sit ups  
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
Day 3  Stiff leg deadlift Push up High Pulls Dumbbell row Ab plank 
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
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WEEK 10       
Day 1  Squats Bench Press Military Press Sit ups  
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
Day 2  Stiff leg deadlift Push up High Pulls Dumbbell row Ab plank 
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
Day 3  Squats Bench Press Military Press Sit ups  
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
       
WEEK 11       
Day 1  Stiff leg deadlift Push up High Pulls Dumbbell row Ab plank 
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
Day 2  Squats Bench Press Military Press Sit ups  
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
Day 3  Stiff leg deadlift Push up High Pulls Dumbbell row Ab plank 
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
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Resistance training Weeks 12-16 
Alternate days – 90% - 3-5 reps per set      5 sets per exercise 
3 second lift – hold for 1 second – lower as quickly as possible           **Please record date, weight lifted and number of reps each day 
2-3 minute rest between exercises, supersets 
 
 
WEEK 12       
Day 1  Squats Bench Press Military Press Sit ups  
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
       
Day 2  Stiff leg deadlift Push up High Pulls Dumbbell row Ab plank 
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
       
Day 3  Squats Bench Press Military Press Sit ups  
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:     
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WEEK 13       
Day 1  Stiff leg deadlift Push up High Pulls Dumbbell row Ab plank 
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
Day 2  Squats Bench Press Military Press Sit ups  
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
Day 3  Stiff leg deadlift Push up High Pulls Dumbbell row Ab plank 
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
WEEK 14       
Day 1  Squats Bench Press Military Press Sit ups  
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
Day 2  Stiff leg deadlift Push up High Pulls Dumbbell row Ab plank 
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
Day 3  Squats Bench Press Military Press Sit ups  
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:     
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WEEK 15       
Day 1  Stiff leg deadlift Push up High Pulls Dumbbell row Ab plank 
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
Day 2  Squats Bench Press Military Press Sit ups  
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
Day 3  Stiff leg deadlift Push up High Pulls Dumbbell row Ab plank 
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
WEEK 16       
Day 1  Squats Bench Press Military Press Sit ups  
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
Day 2  Stiff leg deadlift Push up High Pulls Dumbbell row Ab plank 
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:      
Day 3  Squats Bench Press Military Press Sit ups  
Date: Number of Sets      
 Number of Reps      
 Pounds lifted:     
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Stages of Exercise: 
 
Week 1:  Familiarization 
 3 days per week, 1 set of all exercises, 60% of One Repetition Max (RM).   
3-0-3 tempo: 3 seconds down, hold for 0 seconds, and 3 seconds up.  45-60 
seconds between each exercise.  10-15 reps of each exercise. 
 
Weeks 2-6:  Hypertrophy 
 Alternating days of the split routine.  70% 1RM, 10-15 reps per set, 3 sets,  
3-0-3 tempo, 45-60 seconds rest.  Straight set method (doing all 3 sets of one 
exercise and then moving onto next exercise) or superset method (doing one set of 
one exercise and then one set of the next until you have done all exercises for that 
day and then cycle back through all exercises until you finished all 3 sets for 
each). 
 
Weeks 7-16:  Strength 
 Alternating days, 85% 1RM, 5-8 reps per set, 4-5 sets, 2-0-2 tempo, 2 minutes 
rest between each.  Superset method. 
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Day 1 Exercises: 
 
Squats:  Start standing up with dumbbells at side with feet shoulder width apart and 
slowly sit down as if sitting in a chair.  Make sure knees do not go in front of 
ankles.  Go down until butt is at a 90 degree angle with knees.  Arms can be at 
side or above shoulders with elbows bent. 
Bench Press:  Can be done lying on ball or floor.  On floor, lay down with back flat on 
floor and legs straight.  Hold dumbbells in each hand and raise arms extending 
from shoulders, straight up.  Arms should be directly over chest with elbows 
extending as you raise arms and elbows bending as you come back down.  On 
ball, rest upper back on the ball in a backbend position with feet flat on the floor, 
shoulder width apart and extend arms from shoulders, straight up.  Make sure to 
keep abs parallel with the floor and push hips up toward ceiling. 
Standing Military Press:  Stand straight up with feet shoulder width apart.  Hold 
dumbbells in each hand and raise arms straight up toward ceiling directly from 
shoulders (i.e. start with elbows bent and raise arms up).   
OR Push Press:  Same thing as military press, but for variation add squatting down 
like as in the squats and as the legs become straight then push arms up in the air 
overhead. 
Abdominal Sit-up:  Lay down on floor with feet flat on the floor and knees raised.  
Raise upper back until elbows (or hands, depending on position) touch knees. 
Easiest:  Start sitting up and slowly with control lower back to the floor. 
Next: Start lying down and go up to knees and back down with arms straight out 
towards knees. 
Next:  Same as above, but cross arms over chest. 
Next:  Same as above, but arms are behind neck with elbows bent.  Make sure 
your arms are not pulling on neck and your stomach muscles are doing the 
work. 
Hardest:  Same as above, but do all variations on the ball.  Position similar to 
bench press on the ball (i.e. back bend position).  The farther back your 
back and hips are on the ball, the harder the work-out on the stomach 
muscles. 
OR Crunches:  Lay down on floor with knees bent and feet either up in the air or flat 
on floor.  Raise upper back to a slight curl; do not come up all the way.  
Variations for arms are the same as abdominal sit-ups. 
Wall Sits:  Position back against a wall as if sitting in a chair.  Make sure tops of upper 
leg is parallel to the floor and calf-side of lower leg is parallel to the wall.  Let 
arms rest against back of the wall (i.e. – do not rest hands on hips or legs).  Hold 
for as long as possible while keeping the correct technique. 
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Day 2 Exercises: 
 
Stiff Leg Deadlift:  Start standing up with feet about six inches apart.  Keep knees 
slightly bent and hold dumbbells in each hand.  Slowly bend over as if touching 
toes. 
Pushups:    Lay down with stomach on the floor.  Feet should be about six inches apart.  
With hands shoulder width apart at chest/shoulder level, slowly rise up and then 
back down and repeat.  Shoulders and elbows should be at a 90 degree angle and 
back should remain parallel to the floor, not arched or sagging.   
Easiest:  Bend knees and let knees touch the floor and back should be at an angle 
to the floor as you descend, but make sure back never arches.  Just do the 
down motion and then come up to knees to get back up and then repeat the 
down motion again. 
 Next:  Same position as above but do both ups and downs. 
 Hardest:  First example, on feet (no knees), doing both ups and downs. 
High Pulls:  With feet shoulder width apart and knees slightly bent start with arms 
straight by side with dumbbells in hand and lift fists straight up so that elbows are 
bent and straight out and then go back down to straighten elbows.  Like rowing, 
but pulling up towards ceiling. 
Bent Over Dumbbell Row:  With back straight, but slightly bent over, hold dumbbells 
in each hand and keep arms in 90 degree angle, while raising arms straight up, 
while keeping elbows bent.  Feet should be shoulder width apart with knees 
slightly bent. 
Abdominal Plank (or straight leg sit-up):  Start with stomach on the floor and place 
elbows on the floor with arms bent.  Elbows should be anywhere from under chest 
to further out towards the head, but inside the body.  Hold body up and keep back 
straight, not arched or sagging.  Hold position for as long as you can.  Start with 
5-10 seconds and work up to 30 seconds.  When you can do that, move up to the 
next level trying to achieve one minute or more. 
Easiest:  Elbows under chest and on knees with legs bent and back at an angle. 
 Next:  Extend elbows further out toward head or further out. 
 Next:  Move up to feet only and keep legs straight. 
Hardest:  On feet and elbows bent on floor under head or further out. 
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